{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Open source model and data reviews, for variants / AEs\n",
    "\n",
    "Related thoughts for use cases: \n",
    "- https://docs.google.com/document/d/1HDpOcQQOmT5A398j_qr-Hm3my4fjuZd8To1YTXhlXNg/edit?tab=t.0#heading=h.kt9y0vodzhfp\n",
    "- https://docs.google.com/document/d/1KGyr_zPBAdTophA-XGzkW0ObhVNMoKBhioJdpVpdnA0/edit?tab=t.0#heading=h.kfugo3aqnalh\n",
    "    - With this second example, we can see value in having models which can capture genevar, drug targets and adverse events"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Beginning with protein structure NER model, sourced from https://huggingface.co/PDBEurope/BiomedNLP-PubMedBERT-ProteinStructure-NER-v3.1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9fb9a93110224798b545add11a444d7c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "tokenizer_config.json:   0%|          | 0.00/394 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ba8d2762d1f44b7b9dfafdc8f3ab16ab",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "vocab.txt: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "59f2ab1fc103436f9459abccd3abbb27",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "special_tokens_map.json:   0%|          | 0.00/125 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "21e2678ef4b9480ea521e26ac9a42d8f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "config.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "41d588648e944a02bde1eb65bdfbf5fa",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "model.safetensors:   0%|          | 0.00/436M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from transformers import AutoTokenizer, AutoModelForTokenClassification\n",
    "\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"PDBEurope/BiomedNLP-PubMedBERT-ProteinStructure-NER-v3.1\")\n",
    "model = AutoModelForTokenClassification.from_pretrained(\"PDBEurope/BiomedNLP-PubMedBERT-ProteinStructure-NER-v3.1\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import requests\n",
    "from pprint import pprint\n",
    "from typing import List, Tuple"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def query_epmc(query: str, page_size: int = 10) -> List:\n",
    "    query = f\"{query} HAS_FT:Y AND OPEN_ACCESS:Y\"\n",
    "    url = \"https://www.ebi.ac.uk/europepmc/webservices/rest/search\"\n",
    "    params = {\n",
    "        \"query\": query,\n",
    "        \"format\": \"json\",\n",
    "        \"pageSize\": page_size\n",
    "    }\n",
    "\n",
    "    resp = requests.get(url, params=params)\n",
    "    resp_json = resp.json()\n",
    "\n",
    "    if 'resultList' in resp_json:\n",
    "        # pprint(resp_json)\n",
    "        pmcids = [i['pmcid'] for i in resp_json['resultList']['result']]\n",
    "        return pmcids\n",
    "    else:\n",
    "        return []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['PMC11843469',\n",
       " 'PMC10823009',\n",
       " 'PMC11301264',\n",
       " 'PMC10788875',\n",
       " 'PMC10232650',\n",
       " 'PMC9235876',\n",
       " 'PMC9293687',\n",
       " 'PMC9725131',\n",
       " 'PMC10016848',\n",
       " 'PMC8495913']"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "papers = query_epmc(query=\"protein variant\")\n",
    "papers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Stuck with BioC given Melanie's model used the same / ease of use\n",
    "def query_bioc(pmid: str) -> List:\n",
    "    resp = requests.get(f\"https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/{pmid}/unicode\")\n",
    "    resp_json = resp.json()\n",
    "    # pprint(resp_json)\n",
    "    text = []\n",
    "    for search_hit in resp_json:\n",
    "        docs = search_hit['documents']\n",
    "        for doc in docs:\n",
    "            passages = doc['passages']\n",
    "            sections = []\n",
    "            for block in passages:\n",
    "                section = block['infons']['section_type']\n",
    "                sections.append(section)\n",
    "                text.append(block['text'])\n",
    "                if section in ['INTRO', 'DISCUSS', 'RESULTS']:\n",
    "                    text.append(block['text'])\n",
    "            # print(list(set(sections)))\n",
    "    return text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {},
   "outputs": [],
   "source": [
    "import torch\n",
    "\n",
    "def run_model(\n",
    "        input_text: List[str],\n",
    "        batch_size: int=4,\n",
    "        max_length: int=512) -> Tuple:\n",
    "\n",
    "    all_results = []\n",
    "    \n",
    "    # Process in batches\n",
    "    for i in range(0, len(input_text), batch_size):\n",
    "        # Get the current batch\n",
    "        batch_texts = input_text[i:i + batch_size]\n",
    "        \n",
    "        # Tokenize and pass to model\n",
    "        inputs = tokenizer(batch_texts, return_tensors=\"pt\", padding=True, truncation=True, max_length=max_length)\n",
    "\n",
    "        with torch.no_grad():\n",
    "            outputs = model(**inputs)\n",
    "\n",
    "        # Decode predictions and configure id to label map\n",
    "        predictions = torch.argmax(outputs.logits, dim=2)\n",
    "        id_to_label = model.config.id2label\n",
    "\n",
    "        # Review predictions\n",
    "        for (original_text, input_ids, prediction_ids) in zip(batch_texts, inputs['input_ids'], predictions):\n",
    "            \n",
    "            # Decode tokens and predictions\n",
    "            tokens = tokenizer.convert_ids_to_tokens(input_ids)\n",
    "            labels = [id_to_label[pred_id.item()] for pred_id in prediction_ids]\n",
    "\n",
    "            entities = []\n",
    "            current_entity = None\n",
    "            \n",
    "            for token, label in zip(tokens, labels):\n",
    "                if token in tokenizer.all_special_tokens:\n",
    "                    continue\n",
    "\n",
    "                if label.startswith(\"B-\"):\n",
    "                    if current_entity:\n",
    "                        entities.append(current_entity)\n",
    "                    \n",
    "                    entity_type = label[2:]\n",
    "                    current_entity = {\"entity\": token.replace(\"##\", \"\"), \"type\": entity_type}\n",
    "                \n",
    "                elif label.startswith(\"I-\"):\n",
    "                    if current_entity:\n",
    "                        if [x for x in [current_entity[\"entity\"], token] if \"-\" in x]: \n",
    "                            token = \" \" + token.replace(\"##\", \"\")\n",
    "                            current_entity[\"entity\"] += token\n",
    "                        else:\n",
    "                            token = \" \" + token.replace(\"##\", \"\")\n",
    "                            current_entity[\"entity\"] += token\n",
    "                    \n",
    "                else:\n",
    "                    if current_entity:\n",
    "                        entities.append(current_entity)\n",
    "                    current_entity = None\n",
    "            \n",
    "            if current_entity:\n",
    "                entities.append(current_entity)\n",
    "\n",
    "            all_results.append((original_text, entities))\n",
    "\n",
    "    return all_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\ndef run_model2(\\n        input_text: List[str],\\n        batch_size: int = 4,\\n        max_length: int = 512) -> Tuple:\\n    \"\"\"\\n    Runs a named entity recognition (NER) model on a list of text inputs.\\n    This version correctly combines \\'B-\\' and \\'I-\\' parts of an entity.\\n\\n    Args:\\n        input_text (List[str]): A list of strings to process.\\n        batch_size (int, optional): The number of texts to process in a single batch. Defaults to 4.\\n        max_length (int, optional): The maximum length for tokenization. Defaults to 512.\\n\\n    Returns:\\n        Tuple: A tuple containing a list of tuples. Each inner tuple contains the\\n               original text and a list of identified entities.\\n    \"\"\"\\n    all_results = []\\n    \\n    # Process in batches\\n    for i in range(0, len(input_text), batch_size):\\n        # Get the current batch\\n        batch_texts = input_text[i:i + batch_size]\\n        \\n        # Tokenize and pass to model\\n        inputs = tokenizer(batch_texts, return_tensors=\"pt\", padding=True, truncation=True, max_length=max_length)\\n        inputs.to(\\'cuda\\' if torch.cuda.is_available() else \\'cpu\\') # Move tensors to GPU if available\\n\\n        with torch.no_grad():\\n            outputs = model(**inputs)\\n\\n        # Decode predictions and configure id to label map\\n        predictions = torch.argmax(outputs.logits, dim=2)\\n        id_to_label = model.config.id2label\\n\\n        # Review predictions\\n        for (original_text, input_ids, prediction_ids) in zip(batch_texts, inputs[\\'input_ids\\'], predictions):\\n            \\n            # Decode tokens and predictions\\n            tokens = tokenizer.convert_ids_to_tokens(input_ids)\\n            labels = [id_to_label[pred_id.item()] for pred_id in prediction_ids]\\n\\n            entities = []\\n            current_entity = None\\n            \\n            for token, label in zip(tokens, labels):\\n                # Skip special tokens\\n                if token in tokenizer.all_special_tokens:\\n                    continue\\n                \\n                # Check for beginning of an entity\\n                if label.startswith(\"B-\"):\\n                    # If there was a previous entity, append it\\n                    if current_entity:\\n                        entities.append(current_entity)\\n                    \\n                    entity_type = label[2:]\\n                    current_entity = {\"entity\": token.replace(\"##\", \"\"), \"type\": entity_type}\\n                \\n                # Check for continuation of an entity\\n                elif label.startswith(\"I-\"):\\n                    # If we are currently inside an entity, append the token\\n                    if current_entity and current_entity[\"type\"] == label[2:]:\\n                        current_entity[\"entity\"] += token.replace(\"##\", \"\").replace(\" \", \"\")\\n                    # If \\'I-\\' label doesn\\'t match the current entity type,\\n                    # treat it as a new entity (or a standalone \\'I-\\' label, common error)\\n                    else:\\n                        if current_entity:\\n                            entities.append(current_entity)\\n                        \\n                        entity_type = label[2:]\\n                        current_entity = {\"entity\": token.replace(\"##\", \"\"), \"type\": entity_type}\\n\\n                # Check for \\'O\\' / other labels\\n                else:\\n                    # If there was an entity, append it\\n                    if current_entity:\\n                        entities.append(current_entity)\\n                    current_entity = None\\n            \\n            # Append the last entity if the loop ends while one is present\\n            if current_entity:\\n                entities.append(current_entity)\\n\\n            # Append the result for the current text\\n            all_results.append((original_text, entities))\\n\\n    return all_results\\n    '"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "'''\n",
    "def run_model2(\n",
    "        input_text: List[str],\n",
    "        batch_size: int = 4,\n",
    "        max_length: int = 512) -> Tuple:\n",
    "    \"\"\"\n",
    "    Runs a named entity recognition (NER) model on a list of text inputs.\n",
    "    This version correctly combines 'B-' and 'I-' parts of an entity.\n",
    "\n",
    "    Args:\n",
    "        input_text (List[str]): A list of strings to process.\n",
    "        batch_size (int, optional): The number of texts to process in a single batch. Defaults to 4.\n",
    "        max_length (int, optional): The maximum length for tokenization. Defaults to 512.\n",
    "\n",
    "    Returns:\n",
    "        Tuple: A tuple containing a list of tuples. Each inner tuple contains the\n",
    "               original text and a list of identified entities.\n",
    "    \"\"\"\n",
    "    all_results = []\n",
    "    \n",
    "    # Process in batches\n",
    "    for i in range(0, len(input_text), batch_size):\n",
    "        # Get the current batch\n",
    "        batch_texts = input_text[i:i + batch_size]\n",
    "        \n",
    "        # Tokenize and pass to model\n",
    "        inputs = tokenizer(batch_texts, return_tensors=\"pt\", padding=True, truncation=True, max_length=max_length)\n",
    "        inputs.to('cuda' if torch.cuda.is_available() else 'cpu') # Move tensors to GPU if available\n",
    "\n",
    "        with torch.no_grad():\n",
    "            outputs = model(**inputs)\n",
    "\n",
    "        # Decode predictions and configure id to label map\n",
    "        predictions = torch.argmax(outputs.logits, dim=2)\n",
    "        id_to_label = model.config.id2label\n",
    "\n",
    "        # Review predictions\n",
    "        for (original_text, input_ids, prediction_ids) in zip(batch_texts, inputs['input_ids'], predictions):\n",
    "            \n",
    "            # Decode tokens and predictions\n",
    "            tokens = tokenizer.convert_ids_to_tokens(input_ids)\n",
    "            labels = [id_to_label[pred_id.item()] for pred_id in prediction_ids]\n",
    "\n",
    "            entities = []\n",
    "            current_entity = None\n",
    "            \n",
    "            for token, label in zip(tokens, labels):\n",
    "                # Skip special tokens\n",
    "                if token in tokenizer.all_special_tokens:\n",
    "                    continue\n",
    "                \n",
    "                # Check for beginning of an entity\n",
    "                if label.startswith(\"B-\"):\n",
    "                    # If there was a previous entity, append it\n",
    "                    if current_entity:\n",
    "                        entities.append(current_entity)\n",
    "                    \n",
    "                    entity_type = label[2:]\n",
    "                    current_entity = {\"entity\": token.replace(\"##\", \"\"), \"type\": entity_type}\n",
    "                \n",
    "                # Check for continuation of an entity\n",
    "                elif label.startswith(\"I-\"):\n",
    "                    # If we are currently inside an entity, append the token\n",
    "                    if current_entity and current_entity[\"type\"] == label[2:]:\n",
    "                        current_entity[\"entity\"] += token.replace(\"##\", \"\").replace(\" \", \"\")\n",
    "                    # If 'I-' label doesn't match the current entity type,\n",
    "                    # treat it as a new entity (or a standalone 'I-' label, common error)\n",
    "                    else:\n",
    "                        if current_entity:\n",
    "                            entities.append(current_entity)\n",
    "                        \n",
    "                        entity_type = label[2:]\n",
    "                        current_entity = {\"entity\": token.replace(\"##\", \"\"), \"type\": entity_type}\n",
    "\n",
    "                # Check for 'O' / other labels\n",
    "                else:\n",
    "                    # If there was an entity, append it\n",
    "                    if current_entity:\n",
    "                        entities.append(current_entity)\n",
    "                    current_entity = None\n",
    "            \n",
    "            # Append the last entity if the loop ends while one is present\n",
    "            if current_entity:\n",
    "                entities.append(current_entity)\n",
    "\n",
    "            # Append the result for the current text\n",
    "            all_results.append((original_text, entities))\n",
    "\n",
    "    return all_results\n",
    "    '''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {},
   "outputs": [],
   "source": [
    "# test = run_model2(input_text)\n",
    "# filter_res(test, \"mutant\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 158,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/withers/GitProjects/OTAR3088/ner-model/lib/python3.10/site-packages/torch/nn/modules/module.py:1762: FutureWarning: `encoder_attention_mask` is deprecated and will be removed in version 4.55.0 for `BertSdpaSelfAttention.forward`.\n",
      "  return forward_call(*args, **kwargs)\n"
     ]
    }
   ],
   "source": [
    "input_text = query_bioc(pmid=papers[0])\n",
    "# len(texts)\n",
    "e = run_model(input_text=input_text)\n",
    "# for (text, entity) in e:\n",
    "#     if entity['type'] == \"mutant\":\n",
    "#         print(\"Original text:\")\n",
    "#         pprint([x for x in original_text.split(sep='. ')])\n",
    "#         print(f\"Found term: {entity['entity']}\\n - - - - - - - - -\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 159,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- - - - - - Original text - - - - -\n",
      "['Antibodies are critical tools in medicine and research, and their affinity '\n",
      " 'for their target antigens is a key determinant of their efficacy',\n",
      " 'Traditional antibody affinity maturation and interaction analyses are often '\n",
      " 'hampered by time‐consuming steps such as cloning, expression, purification, '\n",
      " 'and interaction assays',\n",
      " 'To address this, we have developed FASTIA (Fast Affinity Screening '\n",
      " 'Technology for Interaction Analysis), a novel platform that integrates rapid '\n",
      " 'gene fragment preparation, cell‐free protein synthesis, and bio‐layer '\n",
      " 'interferometry with non‐regenerative analysis',\n",
      " 'Using this approach, we can analyze the intermolecular interactions of over '\n",
      " '20 variants over 2\\u2009days, requiring only the parent protein expression '\n",
      " 'plasmid and basic equipment',\n",
      " 'We have demonstrated the ability of FASTIA to discriminate between '\n",
      " 'single‐domain antibody variants with different binding affinities using the '\n",
      " 'anti‐HEL VHH antibody D2‐L29, and mapped the results to the crystal '\n",
      " 'structure to identify key interaction sites',\n",
      " 'FASTIA provides results comparable to those obtained using traditional '\n",
      " 'methods',\n",
      " 'Our system bypasses the need for genetic engineering facilities and can be '\n",
      " 'easily adopted by laboratories, accelerating the protein engineering and '\n",
      " 'optimization processes',\n",
      " 'In addition, FASTIA is applicable to other protein–protein interactions, '\n",
      " 'making it a versatile tool for studying molecular recognition',\n",
      " 'FASTIA facilitates efficient affinity maturation, protein engineering, and '\n",
      " 'analysis of protein–protein interactions',\n",
      " 'This provides a rapid and accessible route for improving antibodies and a '\n",
      " 'broader understanding of protein interactions.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['As a model system, we used the anti‐hen egg white lysozyme (HEL) VHH '\n",
      " 'antibody D2‐L29 (De Genst et al.,\\xa0)',\n",
      " 'In order to investigate the interaction of the antibody with its antigen '\n",
      " 'HEL, we generated a comprehensive panel of 21 alanine mutants across all CDR '\n",
      " 'residues known to interact with the antigen according to structural studies',\n",
      " 'To prepare DNA templates for cell‐free expression using the PUREfrex system, '\n",
      " 'we constructed a plasmid containing the D2‐L29 gene downstream of the T7 '\n",
      " 'promoter, incorporating a C‐terminal 10xHis‐tag',\n",
      " 'This plasmid was then used as a template for PCR amplification of linear DNA '\n",
      " 'fragments incorporating the desired mutations',\n",
      " 'For each mutation, PCR primers were designed that introduced a specific '\n",
      " 'amino acid substitution and created an overlapping region for subsequent '\n",
      " 'assembly',\n",
      " 'Following PCR and DpnI digestion to remove the original plasmid template, '\n",
      " 'linear DNA fragments were assembled into circular plasmids using the '\n",
      " 'NEBuilder HiFi DNA Assembly',\n",
      " 'Finally, the region between the T7 promoter and the gene and the resulting '\n",
      " 'fragments were amplified by PCR and sequenced using Sanger sequencing to '\n",
      " 'confirm the presence of the desired mutation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9', 'd2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['As a model system, we used the anti‐hen egg white lysozyme (HEL) VHH '\n",
      " 'antibody D2‐L29 (De Genst et al.,\\xa0)',\n",
      " 'In order to investigate the interaction of the antibody with its antigen '\n",
      " 'HEL, we generated a comprehensive panel of 21 alanine mutants across all CDR '\n",
      " 'residues known to interact with the antigen according to structural studies',\n",
      " 'To prepare DNA templates for cell‐free expression using the PUREfrex system, '\n",
      " 'we constructed a plasmid containing the D2‐L29 gene downstream of the T7 '\n",
      " 'promoter, incorporating a C‐terminal 10xHis‐tag',\n",
      " 'This plasmid was then used as a template for PCR amplification of linear DNA '\n",
      " 'fragments incorporating the desired mutations',\n",
      " 'For each mutation, PCR primers were designed that introduced a specific '\n",
      " 'amino acid substitution and created an overlapping region for subsequent '\n",
      " 'assembly',\n",
      " 'Following PCR and DpnI digestion to remove the original plasmid template, '\n",
      " 'linear DNA fragments were assembled into circular plasmids using the '\n",
      " 'NEBuilder HiFi DNA Assembly',\n",
      " 'Finally, the region between the T7 promoter and the gene and the resulting '\n",
      " 'fragments were amplified by PCR and sequenced using Sanger sequencing to '\n",
      " 'confirm the presence of the desired mutation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9', 'd2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['The prepared PCR fragments were used as templates for cell‐free protein '\n",
      " 'synthesis with the PUREfrex system',\n",
      " 'Each construct was synthesized in a 10\\u2009μL reaction at 30°C for 3–4\\u2009'\n",
      " 'h',\n",
      " 'The successful expression of D2‐L29 and its variants was confirmed using '\n",
      " 'western blotting (Figure\\xa0S2).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['The prepared PCR fragments were used as templates for cell‐free protein '\n",
      " 'synthesis with the PUREfrex system',\n",
      " 'Each construct was synthesized in a 10\\u2009μL reaction at 30°C for 3–4\\u2009'\n",
      " 'h',\n",
      " 'The successful expression of D2‐L29 and its variants was confirmed using '\n",
      " 'western blotting (Figure\\xa0S2).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['To prepare for BLI analysis, the reaction mixture was diluted in buffer and '\n",
      " 'loaded onto a BLI biosensor pre‐coated with an anti‐penta‐His antibody, thus '\n",
      " 'specifically capturing the expressed VHH',\n",
      " 'Subsequently, we assessed antibody–HEL interactions',\n",
      " 'In BLI, multiple sensors are typically used to simultaneously measure '\n",
      " 'interactions with different concentrations of an antigen',\n",
      " 'However, this approach necessitates preparing enough antibody to perform '\n",
      " 'measurements at each of these antigen concentrations',\n",
      " 'While measurements can also be performed using a single sensor over multiple '\n",
      " 'cycles, this process involves antibody capture and dissociation in each '\n",
      " 'cycle, making it excessively time‐consuming',\n",
      " 'To address this limitation, we adopted the non‐regenerative kinetics method, '\n",
      " 'also known as the single‐cycle kinetics method (Kamat & Rafique,\\xa0), which '\n",
      " 'enables continuous analysis of antigen interactions across multiple '\n",
      " 'concentrations without the need for complete antigen dissociation',\n",
      " 'The sensorgrams are shown in Figure\\xa02, and the kinetic parameters are '\n",
      " 'listed in Table\\xa01',\n",
      " 'The wild type D2‐L29 antibody exhibited a K D value of 3.6\\u2009nM',\n",
      " 'The alanine mutants exhibited a variety of binding behaviors, including '\n",
      " 'maintained, slightly reduced, and significantly reduced affinities.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['To prepare for BLI analysis, the reaction mixture was diluted in buffer and '\n",
      " 'loaded onto a BLI biosensor pre‐coated with an anti‐penta‐His antibody, thus '\n",
      " 'specifically capturing the expressed VHH',\n",
      " 'Subsequently, we assessed antibody–HEL interactions',\n",
      " 'In BLI, multiple sensors are typically used to simultaneously measure '\n",
      " 'interactions with different concentrations of an antigen',\n",
      " 'However, this approach necessitates preparing enough antibody to perform '\n",
      " 'measurements at each of these antigen concentrations',\n",
      " 'While measurements can also be performed using a single sensor over multiple '\n",
      " 'cycles, this process involves antibody capture and dissociation in each '\n",
      " 'cycle, making it excessively time‐consuming',\n",
      " 'To address this limitation, we adopted the non‐regenerative kinetics method, '\n",
      " 'also known as the single‐cycle kinetics method (Kamat & Rafique,\\xa0), which '\n",
      " 'enables continuous analysis of antigen interactions across multiple '\n",
      " 'concentrations without the need for complete antigen dissociation',\n",
      " 'The sensorgrams are shown in Figure\\xa02, and the kinetic parameters are '\n",
      " 'listed in Table\\xa01',\n",
      " 'The wild type D2‐L29 antibody exhibited a K D value of 3.6\\u2009nM',\n",
      " 'The alanine mutants exhibited a variety of binding behaviors, including '\n",
      " 'maintained, slightly reduced, and significantly reduced affinities.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['BLI sensorgrams of D2‐L29 variants',\n",
      " 'The gray dots represent the reference‐subtracted data, and the colored lines '\n",
      " 'represent the fitting curves',\n",
      " 'Red, 1\\u2009nM HEL; green, 4\\u2009nM HEL; orange, 16\\u2009nM HEL; blue, '\n",
      " '64\\u2009nM HEL.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['Kinetics parameters of D2‐L29 variants.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['\\tThis study (n\\u2009=\\u20093, average\\u2009±\\u2009SD)\\tAkiba et al',\n",
      " '\\t \\tkon\\tkoff\\tKD\\tKD\\t \\t(×105\\u2009M−1\\u2009s−1)\\t(×10−3\\u2009s−1)\\t(nM)\\t'\n",
      " '(nM)\\t \\tWT\\t6.0\\u2009±\\u20090.7\\t1.9\\u2009±\\u20090.5\\t3.1\\u2009±\\u20090.4\\t'\n",
      " '7.6\\u2009±\\u20090.1\\t \\tV2A\\t8.2\\u2009±\\u20090.3\\t1.6\\u2009±\\u20090.2\\t'\n",
      " '2.2\\u2009±\\u20091.1\\t—\\t \\tY29A\\tN.D.\\tN.D.\\tN.D.\\tN.D.\\t \\tK30A\\t7.6\\u2009'\n",
      " '±\\u20091.7\\t2.4\\u2009±\\u20090.8\\t3.1\\u2009±\\u20090.7\\t—\\t \\tN31A\\t6.7\\u2009'\n",
      " '±\\u20092.5\\t2.6\\u2009±\\u20090.3\\t4.5\\u2009±\\u20092.4\\t23\\u2009±\\u20091\\t \\t'\n",
      " 'F37A\\t4.3\\u2009±\\u20091.7\\t24\\u2009±\\u20094\\t62\\u2009±\\u200924\\t—\\t \\tD44A\\t'\n",
      " '6.2\\u2009±\\u20090.9\\t2.4\\u2009±\\u20090.4\\t4.0\\u2009±\\u20091.0\\t—\\t \\tR45A\\t'\n",
      " '6.4\\u2009±\\u20092.5\\t0.48\\u2009±\\u20090.07\\t0.81\\u2009±\\u20090.27\\t—\\t \\t'\n",
      " 'E46A\\t7.4\\u2009±\\u20093.0\\t1.4\\u2009±\\u20090.1\\t2.1\\u2009±\\u20091.0\\t—\\t \\t'\n",
      " 'G47A\\t5.6\\u2009±\\u20091.6\\t0.29\\u2009±\\u20090.06\\t0.54\\u2009±\\u20090.15\\t'\n",
      " '—\\t \\tF50A\\t5.5\\u2009±\\u20091.3\\t8.9\\u2009±\\u20092.0\\t17\\u2009±\\u20098\\t'\n",
      " '—\\t \\tY60A\\t3.7\\u2009±\\u20090.8\\t15\\u2009±\\u20091\\t41\\u2009±\\u20091.3\\t'\n",
      " '533\\u2009±\\u200950a\\t \\tY100A\\tN.D.\\tN.D.\\tN.D.\\tN.D.\\t \\tR101Ab\\t6.7\\u2009'\n",
      " '±\\u20092.1\\t4.8\\u2009±\\u20090.1\\t7.5\\u2009±\\u20092.6\\t—\\t \\tN102A\\t5.4\\u2009'\n",
      " '±\\u20090.8\\t3.7\\u2009±\\u20090.3\\t7.0\\u2009±\\u20091.4\\t50\\u2009±\\u20090\\t \\t'\n",
      " 'Y103A\\t6.0\\u2009±\\u20091.6\\t2.4\\u2009±\\u20090.1\\t4.3\\u2009±\\u20091.4\\t—\\t \\t'\n",
      " 'Q105A\\t6.1\\u2009±\\u20092.0\\t4.7\\u2009±\\u20091.0\\t8.8\\u2009±\\u20095.1\\t'\n",
      " '46\\u2009±\\u20090\\t \\tC106A\\tN.D.\\tN.D.\\tN.D.\\t—\\t \\tT108A\\t4.6\\u2009±\\u2009'\n",
      " '0.0\\t5.3\\u2009±\\u20091.7\\t11\\u2009±\\u20094\\t31\\u2009±\\u20090\\t \\tR109A\\t'\n",
      " 'N.D.\\tN.D.\\tN.D.\\tN.D.\\t \\tY110A\\t5.2\\u2009±\\u20091.0\\t3.4\\u2009±\\u20090.5\\t'\n",
      " '6.8\\u2009±\\u20092.4\\t—\\t \\tW111A\\t4.3\\u2009±\\u20090.8\\t11\\u2009±\\u20091\\t'\n",
      " '25\\u2009±\\u20096\\t99\\u2009±\\u20091\\t \\t']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['v2',\n",
      " 'a',\n",
      " 'y2',\n",
      " '9a',\n",
      " 'k3',\n",
      " '0',\n",
      " 'a',\n",
      " 'n3',\n",
      " '1a',\n",
      " 'f3',\n",
      " '7a',\n",
      " 'd4',\n",
      " '4a',\n",
      " 'r4',\n",
      " '5a',\n",
      " 'e4',\n",
      " '6a',\n",
      " 'g4',\n",
      " '7a',\n",
      " 'f5',\n",
      " '0',\n",
      " 'a',\n",
      " 'y',\n",
      " '60',\n",
      " 'a',\n",
      " 'y1',\n",
      " '00',\n",
      " 'a',\n",
      " 'r1',\n",
      " '01',\n",
      " 'ab',\n",
      " 'n1',\n",
      " '02',\n",
      " 'a',\n",
      " 'y1',\n",
      " '03',\n",
      " 'a',\n",
      " 'q1',\n",
      " '05',\n",
      " 'a',\n",
      " 'c10',\n",
      " '6a',\n",
      " 't1',\n",
      " '08',\n",
      " 'a',\n",
      " 'r1',\n",
      " '09',\n",
      " 'a',\n",
      " 'y1',\n",
      " '10a']\n",
      "- - - - - - Original text - - - - -\n",
      "['Data measured in duplicate are shown for R101A.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '01', 'a']\n",
      "- - - - - - Original text - - - - -\n",
      "['To elucidate the effects of these mutations, the residues were colored '\n",
      " 'according to the change in affinity, and then mapped onto the crystal '\n",
      " 'structure of the D2‐L29‐HEL complex (Figure\\xa03)',\n",
      " 'This revealed that specific regions (Y29, Y100, C106, and R109, shown in '\n",
      " 'red) exhibited a loss of interaction upon mutation, suggesting that they '\n",
      " 'were hotspots for the interaction',\n",
      " 'For C106A, the loss of intermolecular disulfide bridges is presumably '\n",
      " 'responsible for the conformational change in CDR3',\n",
      " 'Furthermore, the residues exhibiting reduced affinity due to mutations (F37, '\n",
      " 'F50, Y60, T108, and W111, shown in magenta), namely those crucial for '\n",
      " 'interactions, were concentrated in specific regions adjacent to the '\n",
      " 'identified hotspot regions',\n",
      " 'Conversely, some residues where the interaction was enhanced by the mutation '\n",
      " '(R45 and G47, shown in blue) were identified, suggesting that optimization '\n",
      " 'of these regions could further enhance the interaction.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c10', '6a']\n",
      "- - - - - - Original text - - - - -\n",
      "['To elucidate the effects of these mutations, the residues were colored '\n",
      " 'according to the change in affinity, and then mapped onto the crystal '\n",
      " 'structure of the D2‐L29‐HEL complex (Figure\\xa03)',\n",
      " 'This revealed that specific regions (Y29, Y100, C106, and R109, shown in '\n",
      " 'red) exhibited a loss of interaction upon mutation, suggesting that they '\n",
      " 'were hotspots for the interaction',\n",
      " 'For C106A, the loss of intermolecular disulfide bridges is presumably '\n",
      " 'responsible for the conformational change in CDR3',\n",
      " 'Furthermore, the residues exhibiting reduced affinity due to mutations (F37, '\n",
      " 'F50, Y60, T108, and W111, shown in magenta), namely those crucial for '\n",
      " 'interactions, were concentrated in specific regions adjacent to the '\n",
      " 'identified hotspot regions',\n",
      " 'Conversely, some residues where the interaction was enhanced by the mutation '\n",
      " '(R45 and G47, shown in blue) were identified, suggesting that optimization '\n",
      " 'of these regions could further enhance the interaction.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c10', '6a']\n",
      "- - - - - - Original text - - - - -\n",
      "['Crystal structure of D2‐L29 in complex with HEL',\n",
      " 'The results of the alanine scanning experiment using FASTIA were mapped onto '\n",
      " 'the crystal structure',\n",
      " '(a) The surface of HEL is shown in light blue and the structure of D2‐L29 is '\n",
      " 'shown as a ribbon',\n",
      " 'CDRs (Chothia definition) are highlighted in orange',\n",
      " 'Labeled residues indicated with side chains are the target residues for '\n",
      " 'which variants were created in this study',\n",
      " '(b) Surface of D2‐L29 is shown',\n",
      " 'The coloring of the residues was based on the criteria described in the '\n",
      " 'following',\n",
      " 'Red, residues that lost interaction due to Ala mutation; magenta, residues '\n",
      " 'with more than 3‐fold decrease in affinity due to Ala mutation; green, '\n",
      " 'residues whose affinity was not severely altered by Ala mutation (1/3 to '\n",
      " '3‐fold); blue, residues with more than 3‐fold increase in affinity due to '\n",
      " 'Ala mutation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9', 'd2 ‐ l2 9', 'd2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['Analysis of the alanine scan data revealed that CDR3 plays a central role in '\n",
      " 'the interaction between D2‐L29 and HEL, consistent with its location in the '\n",
      " 'antibody–antigen interface',\n",
      " 'Several mutations within CDR3, including Y100A, C106A, T108A, and R109A, '\n",
      " 'resulted in a significant or complete loss of binding affinity (Table\\xa01, '\n",
      " 'Figure\\xa03)',\n",
      " 'Our results also demonstrate that framework regions (FRs) contribute to '\n",
      " 'antigen binding',\n",
      " 'In particular, F37A, F50A, Y60A, and W111A showed significant loss of '\n",
      " 'affinity',\n",
      " 'On the other hand, mutations in FR residues located at the periphery of the '\n",
      " 'interaction interface, such as R45A and G47A, led to a notable increase in '\n",
      " 'affinity (Table\\xa01, Figure\\xa03).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['y1',\n",
      " '00',\n",
      " 'a',\n",
      " 'c10',\n",
      " '6a',\n",
      " 't1',\n",
      " '08',\n",
      " 'a',\n",
      " 'r1',\n",
      " '09',\n",
      " 'a',\n",
      " 'f3',\n",
      " '7a',\n",
      " 'f5',\n",
      " '0',\n",
      " 'a',\n",
      " 'y',\n",
      " '60',\n",
      " 'a',\n",
      " 'w1',\n",
      " '11a',\n",
      " 'r4',\n",
      " '5a',\n",
      " 'g4',\n",
      " '7a']\n",
      "- - - - - - Original text - - - - -\n",
      "['Analysis of the alanine scan data revealed that CDR3 plays a central role in '\n",
      " 'the interaction between D2‐L29 and HEL, consistent with its location in the '\n",
      " 'antibody–antigen interface',\n",
      " 'Several mutations within CDR3, including Y100A, C106A, T108A, and R109A, '\n",
      " 'resulted in a significant or complete loss of binding affinity (Table\\xa01, '\n",
      " 'Figure\\xa03)',\n",
      " 'Our results also demonstrate that framework regions (FRs) contribute to '\n",
      " 'antigen binding',\n",
      " 'In particular, F37A, F50A, Y60A, and W111A showed significant loss of '\n",
      " 'affinity',\n",
      " 'On the other hand, mutations in FR residues located at the periphery of the '\n",
      " 'interaction interface, such as R45A and G47A, led to a notable increase in '\n",
      " 'affinity (Table\\xa01, Figure\\xa03).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['y1',\n",
      " '00',\n",
      " 'a',\n",
      " 'c10',\n",
      " '6a',\n",
      " 't1',\n",
      " '08',\n",
      " 'a',\n",
      " 'r1',\n",
      " '09',\n",
      " 'a',\n",
      " 'f3',\n",
      " '7a',\n",
      " 'f5',\n",
      " '0',\n",
      " 'a',\n",
      " 'y',\n",
      " '60',\n",
      " 'a',\n",
      " 'w1',\n",
      " '11a',\n",
      " 'r4',\n",
      " '5a',\n",
      " 'g4',\n",
      " '7a']\n",
      "- - - - - - Original text - - - - -\n",
      "['The gene encoding the anti‐HEL antibody VHH, D2‐L29, was cloned into a '\n",
      " 'pET28b‐based expression vector under the control of the T7 promoter '\n",
      " 'containing a C‐terminal 10xHis‐tag for purification and detection (Figure\\xa0'\n",
      " 'S1)',\n",
      " 'The resulting plasmid served as a template for constructing the '\n",
      " 'antibody‐variant genes.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d2 ‐ l2 9']\n",
      "- - - - - - Original text - - - - -\n",
      "['A panel of 21 alanine mutants targeting all CDR residues of the D2‐L29 VHH '\n",
      " 'was designed based on the crystal structure of the D2‐L29‐HEL complex (PDB '\n",
      " 'ID: 1ZV5), specifically targeting residues with a buried surface area (BSA) '\n",
      " 'greater than 0\\u2009Å2 as determined by PDBePISA (Krissinel & Henrick,\\xa0).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['alanine mutants', 'd2 ‐ l2 9']\n"
     ]
    }
   ],
   "source": [
    "def filter_res(results: List[Tuple], filter: str):\n",
    "    for res in results:\n",
    "        text = res[0]\n",
    "        tagged = res[1]\n",
    "        filtered = [x[\"entity\"] for x in tagged if x[\"type\"] == filter]\n",
    "        if len(filtered) > 0:\n",
    "            print(\"- - - - - - Original text - - - - -\")\n",
    "            pprint([x for x in text.split(sep='. ')])\n",
    "            print(f\"- - Terms tagged of type '{filter}' - -\")\n",
    "            pprint(filtered)\n",
    "\n",
    "filter_res(e, \"mutant\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/withers/GitProjects/OTAR3088/ner-model/lib/python3.10/site-packages/torch/nn/modules/module.py:1762: FutureWarning: `encoder_attention_mask` is deprecated and will be removed in version 4.55.0 for `BertSdpaSelfAttention.forward`.\n",
      "  return forward_call(*args, **kwargs)\n"
     ]
    }
   ],
   "source": [
    "for p in papers:\n",
    "    e = run_model(input_text=p)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Some gemini example sentences, these are more obvious examples of variants\n",
    "protein_variant_sentences = [\n",
    "    \"Studies on the protein-protein interaction network revealed that the R175H variant of p53 dramatically alters its binding partners, shifting its function from a tumor suppressor to an oncogenic driver.\",\n",
    "    \"The structural consequences of the E6V substitution in hemoglobin are profound, leading to the formation of rigid polymers that deform red blood cells into their characteristic sickle shape.\",\n",
    "    \"The D90A mutation in superoxide dismutase 1 (SOD1) highlights the complexity of disease mechanisms, as its pathogenicity in familial ALS is not due to a loss of catalytic activity but rather to a gain of toxic function.\",\n",
    "    \"The ΔF508 deletion in the CFTR protein prevents its proper folding, triggering the cell's quality control system to target the misfolded protein for destruction in the endoplasmic reticulum.\",\n",
    "    \"Kinase inhibitors are now a standard therapy for melanoma patients with the V600E mutation in BRAF, which constitutively activates the downstream signaling cascade.\",\n",
    "    \"The single amino acid change A67T in transthyretin increases its propensity to misfold and aggregate, forming amyloid fibrils that deposit in the heart and other tissues.\",\n",
    "    \"The pathogenicity of the A223P variant in fibrillin-1 lies in its disruption of calcium-binding sites, which are critical for the formation of stable microfibrils in the extracellular matrix.\",\n",
    "    \"Patients with familial chylomicronemia resulting from the S267L variant of lipoprotein lipase exhibit severely impaired lipid clearance due to the protein's reduced catalytic efficiency.\",\n",
    "    \"The R117H amino acid substitution in Factor V makes it resistant to cleavage by activated protein C, a critical step in down-regulating blood coagulation.\",\n",
    "    \"The P101S amino acid change in the prion protein (PrP) is a crucial determinant of disease pathology, as it favors the conversion of the normal PrP ($PrP^C$) into the disease-associated scrapie form ($PrP^{Sc}$).\",\n",
    "    \"The E280A mutation in presenilin 1 alters the cleavage of the amyloid precursor protein (APP), leading to an overproduction of the highly aggregation-prone Aβ42 peptide.\",\n",
    "    \"Achondroplasia is caused by a G380R variant in fibroblast growth factor receptor 3 (FGFR3), which leads to the constitutive activation of the receptor even in the absence of its ligand.\",\n",
    "    \"The K456N variant of cardiac troponin I impairs the calcium-dependent regulation of myocardial contraction, which is the underlying cause of hypertrophic cardiomyopathy.\",\n",
    "    \"The C278F substitution in fibroblast growth factor receptor 2 (FGFR2) is a well-known example of a gain-of-function mutation, leading to premature fusion of the cranial sutures.\",\n",
    "    \"The C282Y variant in the HFE protein disrupts its interaction with the transferrin receptor, leading to a breakdown in the regulation of iron absorption.\",\n",
    "    \"The p.L320P variant of lamin A/C causes dilated cardiomyopathy by compromising the structural integrity of the nuclear lamina and disrupting normal gene expression patterns.\",\n",
    "    \"The S295C mutation in myotilin creates a new cysteine residue, which can form inappropriate disulfide bonds, leading to the formation of aggregates that interfere with muscle function.\",\n",
    "    \"The R402Q variant in the ATP-binding cassette transporter A4 (ABCA4) disrupts its ability to transport retinoids, leading to the accumulation of toxic compounds in the retinal pigment epithelium.\",\n",
    "    \"A study of familial ALS patients identified the H46R mutation in SOD1, which was shown to lead to a misfolding and aggregation of the protein that is toxic to motor neurons.\",\n",
    "    \"The E258K mutation in lysosomal acid lipase is a clear example of a loss-of-function variant, as it severely impairs the protein's ability to hydrolyze cholesterol esters.\",\n",
    "    \"Individuals homozygous for the M34T variant in connexin 26 (GJB2) often present with non-syndromic hearing loss due to the disruption of gap junction function in the inner ear.\",\n",
    "    \"Congenital contractural arachnodactyly is associated with the K197R mutation in fibrillin-2, a protein crucial for elastic fiber formation in connective tissues.\",\n",
    "    \"The L268P mutation in type II collagen (COL2A1) results in a protein with impaired triple helix formation, leading to the skeletal abnormalities characteristic of Stickler syndrome.\",\n",
    "    \"The P1213L variant in dynein heavy chain 1 (DYNC1H1) compromises the protein's motor function, resulting in defects in retrograde axonal transport that cause spinal muscular atrophy.\",\n",
    "    \"The R782W mutation in α₁-antitrypsin (SERPINA1) results in a misfolded protein that is trapped in the liver, leading to a lack of circulating α₁-antitrypsin in the lungs.\",\n",
    "    \"The R136Q amino acid substitution in ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) affects its deubiquitinating activity, which may contribute to the accumulation of protein aggregates observed in Parkinson's disease.\",\n",
    "    \"The P270S variant in glucocerebrosidase (GBA1) has been shown to reduce the enzyme's activity, which is a known risk factor for Parkinson's disease.\",\n",
    "    \"The A30P mutation in α-synuclein is a rare but well-documented cause of familial Parkinson's disease, as it promotes the formation of neurotoxic fibrils and Lewy bodies.\",\n",
    "    \"The R46L variant in proprotein convertase subtilisin/kexin type 9 (PCSK9) is a functional polymorphism that reduces the protein's ability to degrade LDL receptors, leading to lower levels of circulating LDL cholesterol.\",\n",
    "    \"The A152T variant in the protein tau (MAPT) is a known risk factor for frontotemporal dementia, as it enhances the aggregation and misfolding of the protein.\"\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Gemini mimicking descriptions of paper results, for protein variants then non-coding genetic variants to see what happens\n",
    "protein_variant_sentences_experimental_results = [\n",
    "    \"Circular dichroism spectroscopy of the R175H p53 variant revealed a significant decrease in α-helical content compared to the wild-type protein, indicating a loss of structural integrity.\",\n",
    "    \"In our gel electrophoresis assays, the E6V hemoglobin variant showed a distinct band shift in non-denaturing conditions, consistent with polymer formation under deoxygenated states.\",\n",
    "    \"Immunoblot analysis of cells expressing the D90A SOD1 variant demonstrated a marked increase in detergent-insoluble protein, suggesting a propensity for aggregation.\",\n",
    "    \"Western blot analysis of the ΔF508 CFTR variant showed a complete absence of the mature, fully glycosylated band, confirming that the protein is not trafficked to the cell surface.\",\n",
    "    \"In vitro kinase assays confirmed a 500-fold increase in the phosphorylation of ERK and MEK substrates when using the V600E BRAF variant, demonstrating constitutive activation.\",\n",
    "    \"Fluorescence microscopy with Thioflavin S staining revealed abundant amyloid deposits in cardiac tissue sections from mice expressing the A67T transthyretin variant.\",\n",
    "    \"Our surface plasmon resonance (SPR) data demonstrated that the A223P fibrillin-1 variant has a significantly reduced binding affinity for calcium ions (Kd = 450 nM vs 50 nM for WT).\",\n",
    "    \"Lipolysis assays using the S267L lipoprotein lipase variant showed only 15% of the catalytic activity observed with the wild-type enzyme.\",\n",
    "    \"Coagulation assays of plasma containing the R117H Factor V variant showed a 12-fold increase in clotting time after the addition of activated protein C, confirming its resistance to inactivation.\",\n",
    "    \"Real-time quaking-induced conversion (RT-QuIC) assays demonstrated that the P101S prion protein variant seeded the rapid formation of fibrils at a concentration 100-fold lower than the wild-type protein.\",\n",
    "    \"Cell-free cleavage assays confirmed that the E280A presenilin 1 variant preferentially generated the highly amyloidogenic Aβ42 peptide over the Aβ40 peptide.\",\n",
    "    \"Dual-luciferase reporter assays confirmed a 20-fold increase in STAT3 signaling in cells expressing the G380R FGFR3 variant, even in the absence of exogenous FGF ligand.\",\n",
    "    \"Calcium-sensitizing assays on skinned cardiac muscle fibers revealed that the K456N troponin I variant increased the calcium sensitivity of force generation by 2.5-fold.\",\n",
    "    \"Immunofluorescence staining revealed that the C278F FGFR2 variant localized to the cell membrane at a higher density and for a longer duration than the wild-type protein.\",\n",
    "    \"In our iron uptake experiments, cells expressing the C282Y HFE variant failed to show the characteristic down-regulation of transferrin receptor expression in response to high iron levels.\",\n",
    "    \"Immunoblotting of nuclear fractions showed a fragmented lamin A/C network in cells from patients with the p.L320P variant, indicating a loss of nuclear integrity.\",\n",
    "    \"Pull-down assays with a cysteine-reactive probe demonstrated that the S295C myotilin mutation forms intermolecular disulfide bonds, leading to the formation of high-molecular-weight aggregates.\",\n",
    "    \"Liposome-based transport assays using the R402Q ABCA4 variant showed a 90% reduction in the translocation of all-trans-retinal across the membrane.\",\n",
    "    \"Immunohistochemistry of spinal cord sections from transgenic mice expressing the H46R SOD1 variant revealed extensive intracellular inclusions in motor neurons, which were immunoreactive for ubiquitin.\",\n",
    "    \"In vitro enzyme kinetics demonstrated that the E258K lysosomal acid lipase variant had a Vmax that was less than 5% of the wild-type enzyme, confirming a severe loss-of-function.\",\n",
    "    \"Dye-transfer assays showed a complete failure of Lucifer yellow transfer between cells expressing the M34T connexin 26 variant, indicating a loss of gap junction function.\",\n",
    "    \"Atomic force microscopy of extracellular matrix fibers from cells expressing the K197R fibrillin-2 variant revealed an aberrant, disorganized microfibril network.\",\n",
    "    \"A triple helix formation assay using purified L268P collagen type II demonstrated a significant reduction in the protein's ability to form stable triple helices.\",\n",
    "    \"Live-cell imaging of retrograde axonal transport in neurons with the P1213L dynein heavy chain 1 variant showed a 75% decrease in the speed of cargo movement toward the cell body.\",\n",
    "    \"Immunofluorescence of liver tissue from a patient with the R782W α₁-antitrypsin variant revealed abundant inclusions of the protein within hepatocytes, confirming its failure to be secreted.\",\n",
    "    \"The R136Q UCHL1 variant showed a 5-fold decrease in its isopeptidase activity against a ubiquitinated substrate in a mass spectrometry-based enzymatic assay.\",\n",
    "    \"In a fluorometric enzyme assay, the P270S glucocerebrosidase variant exhibited only 40% of the catalytic activity observed with the wild-type protein.\",\n",
    "    \"Transmission electron microscopy of neuronal cultures expressing the A30P α-synuclein variant showed the presence of abundant fibrillar aggregates, similar to those found in Lewy bodies.\",\n",
    "    \"In our binding assays, the R46L PCSK9 variant demonstrated a 3-fold decrease in its binding affinity for the LDL receptor, leading to a reduced rate of receptor degradation.\",\n",
    "    \"Confocal microscopy of cells expressing the A152T tau variant revealed a significant increase in the formation of puncta and filamentous structures, suggesting enhanced aggregation.\"\n",
    "]\n",
    "\n",
    "non_coding_variant_sentences = [\n",
    "    \"Using a dual-luciferase reporter assay, we demonstrated that the SNP rs6983267, located in a long-range enhancer for the MYC oncogene, significantly increased reporter gene expression by 2.5-fold in colon cancer cell lines.\",\n",
    "    \"Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for the transcription factor TCF7L2 revealed a loss of binding at the promoter of the TCF7L2 gene in the presence of the rs7903146 risk allele.\",\n",
    "    \"Our massively parallel reporter assay (MPRA) data showed that the A>T variant in the 3' UTR of the NOS1AP gene reduced the expression of a linked fluorescent reporter by 40% in cardiomyocyte cells.\",\n",
    "    \"Sanger sequencing of the TERT promoter in melanoma samples identified two recurrent non-coding variants, c.-124C>T and c.-146C>T, which were shown by RT-qPCR to increase TERT mRNA expression by 15- and 20-fold, respectively.\",\n",
    "    \"A quantitative chromatin conformation capture (3C) assay demonstrated that the rs9349379 SNP in a genomic insulator element disrupts the physical loop connecting the ESR1 promoter to its upstream enhancer.\",\n",
    "    \"Minigene splicing assays confirmed that the deep intronic variant IVS21-12C>T in the CFTR gene leads to the creation of a cryptic splice site, resulting in a mis-spliced transcript lacking exon 22.\",\n",
    "    \"In a yeast-based screen, we found that a 15-bp deletion within the HBB promoter region completely abolished the binding of the GATA-1 transcription factor, consistent with the observed phenotype in beta-thalassemia patients.\",\n",
    "    \"We performed allelic expression analysis on post-mortem brain tissue and found that the rs12913832 SNP in the OCA2 gene enhancer was strongly associated with a 50% decrease in its expression.\",\n",
    "    \"Our electro mobility shift assay (EMSA) results showed that the C>G SNP in the MDM2 promoter creates a novel high-affinity binding site for the SP1 transcription factor, leading to increased MDM2 transcription.\",\n",
    "    \"RNA-seq analysis of patient-derived lymphoblastoid cell lines with the rs2201397 SNP in the TRIM59 3' UTR showed a significant upregulation of TRIM59 transcript levels, which we hypothesize is due to altered microRNA binding.\",\n",
    "    \"Using CRISPR-Cas9 to introduce the rs7552554 variant in the promoter region of the MYB oncogene, we observed a 3-fold increase in H3K27ac histone marks, indicating enhanced enhancer activity.\",\n",
    "    \"The 5-kb deletion upstream of the SOX2 gene was found to completely abrogate the expression of the gene in embryonic stem cells, suggesting the removal of a critical long-range enhancer.\",\n",
    "    \"In a high-throughput screen, we identified an A>G variant in the promoter of a lncRNA that significantly decreased its transcription by 75% in a disease-relevant cell model.\",\n",
    "    \"Our Northern blot analysis revealed that the rs10825036 SNP in the 3' UTR of the MIR-499 gene resulted in a mature miRNA transcript that was 50% less abundant compared to the wild-type allele.\",\n",
    "    \"Allele-specific chromatin accessibility assays (ATAC-seq) revealed a loss of an open chromatin region at the locus containing the rs12740374 variant, suggesting a disruption of a transcription factor binding site.\",\n",
    "    \"The 3' UTR of the KRAS gene containing the rs61764370 variant was cloned into a reporter plasmid, and subsequent luciferase assays showed a significant reduction in luciferase activity, consistent with altered miRNA-mediated repression.\",\n",
    "    \"Chr-RNA FISH experiments confirmed that the C>T mutation in the SHH limb enhancer region failed to form a chromatin loop with the SHH promoter, explaining the observed limb malformations.\",\n",
    "    \"Reporter gene assays showed that the rs11603334 SNP in the ARAP1 promoter led to a 2-fold upregulation of gene expression in pancreatic beta cells, which was corroborated by decreased binding of PAX4 and PAX6 transcription factors in EMSA.\",\n",
    "    \"We used CRISPR-based tiling scans to systematically test variants in the LDLR promoter, finding that a specific A>C substitution reduced promoter activity by 60%, a key finding for familial hypercholesterolemia.\",\n",
    "    \"RNA-seq of patient tumor samples with the rs73183594 variant in the IRF4 enhancer showed a significant increase in IRF4 mRNA expression levels, suggesting a gain-of-function mechanism.\",\n",
    "    \"Our allele-specific sequencing analysis of RNA from heterozygous individuals demonstrated that the rs3796548 SNP, a non-coding variant, leads to a 3-fold increase in the expression of the TULP3 gene.\",\n",
    "    \"The deletion of an enhancer 150 kb upstream of the GATA6 gene was found to cause a loss of GATA6 protein expression in pancreatic progenitor cells, as confirmed by immunostaining.\",\n",
    "    \"Using a high-resolution 4C-seq, we mapped the chromosomal interactions of the genomic region containing a non-coding variant, revealing the creation of a novel chromatin loop between a distant enhancer and an oncogene.\",\n",
    "    \"A minigene assay showed that a single nucleotide variant (G>A) in the 5' untranslated region of an unknown gene caused an increase in ribosome readthrough and protein translation.\",\n",
    "    \"Quantitative real-time PCR (qRT-PCR) from patient fibroblasts with a deep intronic variant in the IDUA gene revealed a reduced level of the fully spliced transcript and an increase in a mis-spliced isoform.\",\n",
    "    \"The C>G variant in the promoter of the CASP8 gene, located in a CpG island, was shown by methylation-specific PCR to be associated with a complete loss of DNA methylation and subsequent gene silencing.\",\n",
    "    \"In our chromatin accessibility assay, the A>G SNP in the FTO enhancer was found to disrupt the binding of the ARID5B transcription factor, leading to a downstream effect on gene regulation.\",\n",
    "    \"Our reporter assay demonstrated that the rs1403565 variant in the PITX2 enhancer increased the transcriptional activity of a reporter construct by 30% in cardiac tissue cells.\",\n",
    "    \"The insertion of a SINE retrotransposon into the promoter of the FGFR2 gene was shown by reporter assays to completely abolish the gene's promoter activity in fibroblasts.\",\n",
    "    \"CRISPR activation experiments using a sgRNA targeting the promoter region of a lncRNA confirmed that a non-coding variant within this region was responsible for a significant reduction in gene expression.\"\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 147,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- - - - - - Original text - - - - -\n",
      "['Studies on the protein-protein interaction network revealed that the R175H '\n",
      " 'variant of p53 dramatically alters its binding partners, shifting its '\n",
      " 'function from a tumor suppressor to an oncogenic driver.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '75', 'h']\n",
      "- - - - - - Original text - - - - -\n",
      "['The structural consequences of the E6V substitution in hemoglobin are '\n",
      " 'profound, leading to the formation of rigid polymers that deform red blood '\n",
      " 'cells into their characteristic sickle shape.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['e6', 'v']\n",
      "- - - - - - Original text - - - - -\n",
      "['The D90A mutation in superoxide dismutase 1 (SOD1) highlights the complexity '\n",
      " 'of disease mechanisms, as its pathogenicity in familial ALS is not due to a '\n",
      " 'loss of catalytic activity but rather to a gain of toxic function.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d', '90', 'a']\n",
      "- - - - - - Original text - - - - -\n",
      "['The ΔF508 deletion in the CFTR protein prevents its proper folding, '\n",
      " \"triggering the cell's quality control system to target the misfolded protein \"\n",
      " 'for destruction in the endoplasmic reticulum.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['δf', '508']\n",
      "- - - - - - Original text - - - - -\n",
      "['Kinase inhibitors are now a standard therapy for melanoma patients with the '\n",
      " 'V600E mutation in BRAF, which constitutively activates the downstream '\n",
      " 'signaling cascade.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['v600e']\n",
      "- - - - - - Original text - - - - -\n",
      "['The single amino acid change A67T in transthyretin increases its propensity '\n",
      " 'to misfold and aggregate, forming amyloid fibrils that deposit in the heart '\n",
      " 'and other tissues.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a6', '7', 't']\n",
      "- - - - - - Original text - - - - -\n",
      "['The pathogenicity of the A223P variant in fibrillin-1 lies in its disruption '\n",
      " 'of calcium-binding sites, which are critical for the formation of stable '\n",
      " 'microfibrils in the extracellular matrix.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a2', '23', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['Patients with familial chylomicronemia resulting from the S267L variant of '\n",
      " 'lipoprotein lipase exhibit severely impaired lipid clearance due to the '\n",
      " \"protein's reduced catalytic efficiency.\"]\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['s2', '67', 'l']\n",
      "- - - - - - Original text - - - - -\n",
      "['The R117H amino acid substitution in Factor V makes it resistant to cleavage '\n",
      " 'by activated protein C, a critical step in down-regulating blood '\n",
      " 'coagulation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '17', 'h']\n",
      "- - - - - - Original text - - - - -\n",
      "['The P101S amino acid change in the prion protein (PrP) is a crucial '\n",
      " 'determinant of disease pathology, as it favors the conversion of the normal '\n",
      " 'PrP ($PrP^C$) into the disease-associated scrapie form ($PrP^{Sc}$).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p10', '1s']\n",
      "- - - - - - Original text - - - - -\n",
      "['The E280A mutation in presenilin 1 alters the cleavage of the amyloid '\n",
      " 'precursor protein (APP), leading to an overproduction of the highly '\n",
      " 'aggregation-prone Aβ42 peptide.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['e2', '80', 'a']\n",
      "- - - - - - Original text - - - - -\n",
      "['Achondroplasia is caused by a G380R variant in fibroblast growth factor '\n",
      " 'receptor 3 (FGFR3), which leads to the constitutive activation of the '\n",
      " 'receptor even in the absence of its ligand.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['g3', '80', 'r']\n",
      "- - - - - - Original text - - - - -\n",
      "['The K456N variant of cardiac troponin I impairs the calcium-dependent '\n",
      " 'regulation of myocardial contraction, which is the underlying cause of '\n",
      " 'hypertrophic cardiomyopathy.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['k4', '56', 'n']\n",
      "- - - - - - Original text - - - - -\n",
      "['The C278F substitution in fibroblast growth factor receptor 2 (FGFR2) is a '\n",
      " 'well-known example of a gain-of-function mutation, leading to premature '\n",
      " 'fusion of the cranial sutures.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c2', '78', 'f']\n",
      "- - - - - - Original text - - - - -\n",
      "['The C282Y variant in the HFE protein disrupts its interaction with the '\n",
      " 'transferrin receptor, leading to a breakdown in the regulation of iron '\n",
      " 'absorption.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c2', '82', 'y']\n",
      "- - - - - - Original text - - - - -\n",
      "['The p.L320P variant of lamin A/C causes dilated cardiomyopathy by '\n",
      " 'compromising the structural integrity of the nuclear lamina and disrupting '\n",
      " 'normal gene expression patterns.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p .', 'l3', '20', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['The S295C mutation in myotilin creates a new cysteine residue, which can '\n",
      " 'form inappropriate disulfide bonds, leading to the formation of aggregates '\n",
      " 'that interfere with muscle function.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['s2', '95', 'c']\n",
      "- - - - - - Original text - - - - -\n",
      "['The R402Q variant in the ATP-binding cassette transporter A4 (ABCA4) '\n",
      " 'disrupts its ability to transport retinoids, leading to the accumulation of '\n",
      " 'toxic compounds in the retinal pigment epithelium.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r4', '02', 'q']\n",
      "- - - - - - Original text - - - - -\n",
      "['A study of familial ALS patients identified the H46R mutation in SOD1, which '\n",
      " 'was shown to lead to a misfolding and aggregation of the protein that is '\n",
      " 'toxic to motor neurons.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['h4', '6', 'r']\n",
      "- - - - - - Original text - - - - -\n",
      "['The E258K mutation in lysosomal acid lipase is a clear example of a '\n",
      " \"loss-of-function variant, as it severely impairs the protein's ability to \"\n",
      " 'hydrolyze cholesterol esters.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['e2', '58', 'k']\n",
      "- - - - - - Original text - - - - -\n",
      "['Individuals homozygous for the M34T variant in connexin 26 (GJB2) often '\n",
      " 'present with non-syndromic hearing loss due to the disruption of gap '\n",
      " 'junction function in the inner ear.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['m3', '4', 't']\n",
      "- - - - - - Original text - - - - -\n",
      "['Congenital contractural arachnodactyly is associated with the K197R mutation '\n",
      " 'in fibrillin-2, a protein crucial for elastic fiber formation in connective '\n",
      " 'tissues.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['k1', '97', 'r']\n",
      "- - - - - - Original text - - - - -\n",
      "['The L268P mutation in type II collagen (COL2A1) results in a protein with '\n",
      " 'impaired triple helix formation, leading to the skeletal abnormalities '\n",
      " 'characteristic of Stickler syndrome.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['l2', '68', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['The P1213L variant in dynein heavy chain 1 (DYNC1H1) compromises the '\n",
      " \"protein's motor function, resulting in defects in retrograde axonal \"\n",
      " 'transport that cause spinal muscular atrophy.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p12', '13', 'l']\n",
      "- - - - - - Original text - - - - -\n",
      "['The R782W mutation in α₁-antitrypsin (SERPINA1) results in a misfolded '\n",
      " 'protein that is trapped in the liver, leading to a lack of circulating '\n",
      " 'α₁-antitrypsin in the lungs.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r7', '82', 'w']\n",
      "- - - - - - Original text - - - - -\n",
      "['The R136Q amino acid substitution in ubiquitin carboxyl-terminal hydrolase '\n",
      " 'L1 (UCHL1) affects its deubiquitinating activity, which may contribute to '\n",
      " \"the accumulation of protein aggregates observed in Parkinson's disease.\"]\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '36', 'q']\n",
      "- - - - - - Original text - - - - -\n",
      "['The P270S variant in glucocerebrosidase (GBA1) has been shown to reduce the '\n",
      " \"enzyme's activity, which is a known risk factor for Parkinson's disease.\"]\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p27', '0', 's']\n",
      "- - - - - - Original text - - - - -\n",
      "['The A30P mutation in α-synuclein is a rare but well-documented cause of '\n",
      " \"familial Parkinson's disease, as it promotes the formation of neurotoxic \"\n",
      " 'fibrils and Lewy bodies.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a3', '0', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['The R46L variant in proprotein convertase subtilisin/kexin type 9 (PCSK9) is '\n",
      " \"a functional polymorphism that reduces the protein's ability to degrade LDL \"\n",
      " 'receptors, leading to lower levels of circulating LDL cholesterol.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r4', '6', 'l']\n",
      "- - - - - - Original text - - - - -\n",
      "['The A152T variant in the protein tau (MAPT) is a known risk factor for '\n",
      " 'frontotemporal dementia, as it enhances the aggregation and misfolding of '\n",
      " 'the protein.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a1', '52', 't']\n"
     ]
    }
   ],
   "source": [
    "gemini_egs = run_model(input_text=protein_variant_sentences)\n",
    "filter_res(gemini_egs, \"mutant\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- - - - - - Original text - - - - -\n",
      "['Circular dichroism spectroscopy of the R175H p53 variant revealed a '\n",
      " 'significant decrease in α-helical content compared to the wild-type protein, '\n",
      " 'indicating a loss of structural integrity.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '75', 'h']\n",
      "- - - - - - Original text - - - - -\n",
      "['In our gel electrophoresis assays, the E6V hemoglobin variant showed a '\n",
      " 'distinct band shift in non-denaturing conditions, consistent with polymer '\n",
      " 'formation under deoxygenated states.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['e6', 'v']\n",
      "- - - - - - Original text - - - - -\n",
      "['Immunoblot analysis of cells expressing the D90A SOD1 variant demonstrated a '\n",
      " 'marked increase in detergent-insoluble protein, suggesting a propensity for '\n",
      " 'aggregation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['d', '90', 'a']\n",
      "- - - - - - Original text - - - - -\n",
      "['Western blot analysis of the ΔF508 CFTR variant showed a complete absence of '\n",
      " 'the mature, fully glycosylated band, confirming that the protein is not '\n",
      " 'trafficked to the cell surface.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['δf', '508']\n",
      "- - - - - - Original text - - - - -\n",
      "['In vitro kinase assays confirmed a 500-fold increase in the phosphorylation '\n",
      " 'of ERK and MEK substrates when using the V600E BRAF variant, demonstrating '\n",
      " 'constitutive activation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['v600e']\n",
      "- - - - - - Original text - - - - -\n",
      "['Fluorescence microscopy with Thioflavin S staining revealed abundant amyloid '\n",
      " 'deposits in cardiac tissue sections from mice expressing the A67T '\n",
      " 'transthyretin variant.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a6', '7', 't']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our surface plasmon resonance (SPR) data demonstrated that the A223P '\n",
      " 'fibrillin-1 variant has a significantly reduced binding affinity for calcium '\n",
      " 'ions (Kd = 450 nM vs 50 nM for WT).']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a2', '23', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['Lipolysis assays using the S267L lipoprotein lipase variant showed only 15% '\n",
      " 'of the catalytic activity observed with the wild-type enzyme.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['s2', '67', 'l']\n",
      "- - - - - - Original text - - - - -\n",
      "['Coagulation assays of plasma containing the R117H Factor V variant showed a '\n",
      " '12-fold increase in clotting time after the addition of activated protein C, '\n",
      " 'confirming its resistance to inactivation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '17', 'h']\n",
      "- - - - - - Original text - - - - -\n",
      "['Real-time quaking-induced conversion (RT-QuIC) assays demonstrated that the '\n",
      " 'P101S prion protein variant seeded the rapid formation of fibrils at a '\n",
      " 'concentration 100-fold lower than the wild-type protein.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p10', '1s']\n",
      "- - - - - - Original text - - - - -\n",
      "['Cell-free cleavage assays confirmed that the E280A presenilin 1 variant '\n",
      " 'preferentially generated the highly amyloidogenic Aβ42 peptide over the Aβ40 '\n",
      " 'peptide.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['e2', '80', 'a']\n",
      "- - - - - - Original text - - - - -\n",
      "['Dual-luciferase reporter assays confirmed a 20-fold increase in STAT3 '\n",
      " 'signaling in cells expressing the G380R FGFR3 variant, even in the absence '\n",
      " 'of exogenous FGF ligand.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['g3', '80', 'r']\n",
      "- - - - - - Original text - - - - -\n",
      "['Calcium-sensitizing assays on skinned cardiac muscle fibers revealed that '\n",
      " 'the K456N troponin I variant increased the calcium sensitivity of force '\n",
      " 'generation by 2.5-fold.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['k4', '56', 'n']\n",
      "- - - - - - Original text - - - - -\n",
      "['Immunofluorescence staining revealed that the C278F FGFR2 variant localized '\n",
      " 'to the cell membrane at a higher density and for a longer duration than the '\n",
      " 'wild-type protein.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c2', '78', 'f']\n",
      "- - - - - - Original text - - - - -\n",
      "['In our iron uptake experiments, cells expressing the C282Y HFE variant '\n",
      " 'failed to show the characteristic down-regulation of transferrin receptor '\n",
      " 'expression in response to high iron levels.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c2', '82', 'y']\n",
      "- - - - - - Original text - - - - -\n",
      "['Immunoblotting of nuclear fractions showed a fragmented lamin A/C network in '\n",
      " 'cells from patients with the p.L320P variant, indicating a loss of nuclear '\n",
      " 'integrity.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p .', 'l3', '20', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['Pull-down assays with a cysteine-reactive probe demonstrated that the S295C '\n",
      " 'myotilin mutation forms intermolecular disulfide bonds, leading to the '\n",
      " 'formation of high-molecular-weight aggregates.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['s2', '95', 'c']\n",
      "- - - - - - Original text - - - - -\n",
      "['Liposome-based transport assays using the R402Q ABCA4 variant showed a 90% '\n",
      " 'reduction in the translocation of all-trans-retinal across the membrane.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r4', '02', 'q']\n",
      "- - - - - - Original text - - - - -\n",
      "['Immunohistochemistry of spinal cord sections from transgenic mice expressing '\n",
      " 'the H46R SOD1 variant revealed extensive intracellular inclusions in motor '\n",
      " 'neurons, which were immunoreactive for ubiquitin.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['h4', '6', 'r']\n",
      "- - - - - - Original text - - - - -\n",
      "['In vitro enzyme kinetics demonstrated that the E258K lysosomal acid lipase '\n",
      " 'variant had a Vmax that was less than 5% of the wild-type enzyme, confirming '\n",
      " 'a severe loss-of-function.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['e2', '58', 'k']\n",
      "- - - - - - Original text - - - - -\n",
      "['Dye-transfer assays showed a complete failure of Lucifer yellow transfer '\n",
      " 'between cells expressing the M34T connexin 26 variant, indicating a loss of '\n",
      " 'gap junction function.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['m3', '4', 't']\n",
      "- - - - - - Original text - - - - -\n",
      "['Atomic force microscopy of extracellular matrix fibers from cells expressing '\n",
      " 'the K197R fibrillin-2 variant revealed an aberrant, disorganized microfibril '\n",
      " 'network.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['k1', '97', 'r']\n",
      "- - - - - - Original text - - - - -\n",
      "['A triple helix formation assay using purified L268P collagen type II '\n",
      " \"demonstrated a significant reduction in the protein's ability to form stable \"\n",
      " 'triple helices.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['l2', '68', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['Live-cell imaging of retrograde axonal transport in neurons with the P1213L '\n",
      " 'dynein heavy chain 1 variant showed a 75% decrease in the speed of cargo '\n",
      " 'movement toward the cell body.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p12', '13', 'l']\n",
      "- - - - - - Original text - - - - -\n",
      "['Immunofluorescence of liver tissue from a patient with the R782W '\n",
      " 'α₁-antitrypsin variant revealed abundant inclusions of the protein within '\n",
      " 'hepatocytes, confirming its failure to be secreted.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r7', '82', 'w']\n",
      "- - - - - - Original text - - - - -\n",
      "['The R136Q UCHL1 variant showed a 5-fold decrease in its isopeptidase '\n",
      " 'activity against a ubiquitinated substrate in a mass spectrometry-based '\n",
      " 'enzymatic assay.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r1', '36', 'q']\n",
      "- - - - - - Original text - - - - -\n",
      "['In a fluorometric enzyme assay, the P270S glucocerebrosidase variant '\n",
      " 'exhibited only 40% of the catalytic activity observed with the wild-type '\n",
      " 'protein.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['p27', '0', 's']\n",
      "- - - - - - Original text - - - - -\n",
      "['Transmission electron microscopy of neuronal cultures expressing the A30P '\n",
      " 'α-synuclein variant showed the presence of abundant fibrillar aggregates, '\n",
      " 'similar to those found in Lewy bodies.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a3', '0', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['In our binding assays, the R46L PCSK9 variant demonstrated a 3-fold decrease '\n",
      " 'in its binding affinity for the LDL receptor, leading to a reduced rate of '\n",
      " 'receptor degradation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['r4', '6', 'l']\n",
      "- - - - - - Original text - - - - -\n",
      "['Confocal microscopy of cells expressing the A152T tau variant revealed a '\n",
      " 'significant increase in the formation of puncta and filamentous structures, '\n",
      " 'suggesting enhanced aggregation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a1', '52', 't']\n"
     ]
    }
   ],
   "source": [
    "gemini_exps = run_model(input_text=protein_variant_sentences_experimental_results)\n",
    "filter_res(gemini_exps, \"mutant\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 149,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- - - - - - Original text - - - - -\n",
      "['Our massively parallel reporter assay (MPRA) data showed that the A>T '\n",
      " \"variant in the 3' UTR of the NOS1AP gene reduced the expression of a linked \"\n",
      " 'fluorescent reporter by 40% in cardiomyocyte cells.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a > t']\n",
      "- - - - - - Original text - - - - -\n",
      "['Sanger sequencing of the TERT promoter in melanoma samples identified two '\n",
      " 'recurrent non-coding variants, c.-124C>T and c.-146C>T, which were shown by '\n",
      " 'RT-qPCR to increase TERT mRNA expression by 15- and 20-fold, respectively.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c . - 124 c > t', 'c . - 146 c > t']\n",
      "- - - - - - Original text - - - - -\n",
      "['Minigene splicing assays confirmed that the deep intronic variant '\n",
      " 'IVS21-12C>T in the CFTR gene leads to the creation of a cryptic splice site, '\n",
      " 'resulting in a mis-spliced transcript lacking exon 22.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['iv', 's2', '1 - 12 c > t']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our electro mobility shift assay (EMSA) results showed that the C>G SNP in '\n",
      " 'the MDM2 promoter creates a novel high-affinity binding site for the SP1 '\n",
      " 'transcription factor, leading to increased MDM2 transcription.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c > g']\n",
      "- - - - - - Original text - - - - -\n",
      "['Using CRISPR-Cas9 to introduce the rs7552554 variant in the promoter region '\n",
      " 'of the MYB oncogene, we observed a 3-fold increase in H3K27ac histone marks, '\n",
      " 'indicating enhanced enhancer activity.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['rs7', '55', '255', '4']\n",
      "- - - - - - Original text - - - - -\n",
      "['Allele-specific chromatin accessibility assays (ATAC-seq) revealed a loss of '\n",
      " 'an open chromatin region at the locus containing the rs12740374 variant, '\n",
      " 'suggesting a disruption of a transcription factor binding site.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['rs', '127', '403', '74']\n",
      "- - - - - - Original text - - - - -\n",
      "[\"The 3' UTR of the KRAS gene containing the rs61764370 variant was cloned \"\n",
      " 'into a reporter plasmid, and subsequent luciferase assays showed a '\n",
      " 'significant reduction in luciferase activity, consistent with altered '\n",
      " 'miRNA-mediated repression.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['61', '76', '43']\n",
      "- - - - - - Original text - - - - -\n",
      "['Chr-RNA FISH experiments confirmed that the C>T mutation in the SHH limb '\n",
      " 'enhancer region failed to form a chromatin loop with the SHH promoter, '\n",
      " 'explaining the observed limb malformations.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c > t']\n",
      "- - - - - - Original text - - - - -\n",
      "['We used CRISPR-based tiling scans to systematically test variants in the '\n",
      " 'LDLR promoter, finding that a specific A>C substitution reduced promoter '\n",
      " 'activity by 60%, a key finding for familial hypercholesterolemia.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a > c']\n",
      "- - - - - - Original text - - - - -\n",
      "[\"A minigene assay showed that a single nucleotide variant (G>A) in the 5' \"\n",
      " 'untranslated region of an unknown gene caused an increase in ribosome '\n",
      " 'readthrough and protein translation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['g > a']\n",
      "- - - - - - Original text - - - - -\n",
      "['The C>G variant in the promoter of the CASP8 gene, located in a CpG island, '\n",
      " 'was shown by methylation-specific PCR to be associated with a complete loss '\n",
      " 'of DNA methylation and subsequent gene silencing.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['c > g']\n",
      "- - - - - - Original text - - - - -\n",
      "['In our chromatin accessibility assay, the A>G SNP in the FTO enhancer was '\n",
      " 'found to disrupt the binding of the ARID5B transcription factor, leading to '\n",
      " 'a downstream effect on gene regulation.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['a > g']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our reporter assay demonstrated that the rs1403565 variant in the PITX2 '\n",
      " 'enhancer increased the transcriptional activity of a reporter construct by '\n",
      " '30% in cardiac tissue cells.']\n",
      "- - Terms tagged of type 'mutant' - -\n",
      "['rs', '140', '35', '65']\n"
     ]
    }
   ],
   "source": [
    "gemini_gene = run_model(input_text=non_coding_variant_sentences)\n",
    "filter_res(gemini_gene, \"mutant\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 156,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- - - - - - Original text - - - - -\n",
      "['Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for the '\n",
      " 'transcription factor TCF7L2 revealed a loss of binding at the promoter of '\n",
      " 'the TCF7L2 gene in the presence of the rs7903146 risk allele.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['tcf', '7', 'l2', 'tcf', '7', 'l2']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our massively parallel reporter assay (MPRA) data showed that the A>T '\n",
      " \"variant in the 3' UTR of the NOS1AP gene reduced the expression of a linked \"\n",
      " 'fluorescent reporter by 40% in cardiomyocyte cells.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['nos', '1a', 'p']\n",
      "- - - - - - Original text - - - - -\n",
      "['Sanger sequencing of the TERT promoter in melanoma samples identified two '\n",
      " 'recurrent non-coding variants, c.-124C>T and c.-146C>T, which were shown by '\n",
      " 'RT-qPCR to increase TERT mRNA expression by 15- and 20-fold, respectively.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['tert', 'tert']\n",
      "- - - - - - Original text - - - - -\n",
      "['A quantitative chromatin conformation capture (3C) assay demonstrated that '\n",
      " 'the rs9349379 SNP in a genomic insulator element disrupts the physical loop '\n",
      " 'connecting the ESR1 promoter to its upstream enhancer.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['esr1']\n",
      "- - - - - - Original text - - - - -\n",
      "['Minigene splicing assays confirmed that the deep intronic variant '\n",
      " 'IVS21-12C>T in the CFTR gene leads to the creation of a cryptic splice site, '\n",
      " 'resulting in a mis-spliced transcript lacking exon 22.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['cftr']\n",
      "- - - - - - Original text - - - - -\n",
      "['We performed allelic expression analysis on post-mortem brain tissue and '\n",
      " 'found that the rs12913832 SNP in the OCA2 gene enhancer was strongly '\n",
      " 'associated with a 50% decrease in its expression.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['oc', 'a2']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our electro mobility shift assay (EMSA) results showed that the C>G SNP in '\n",
      " 'the MDM2 promoter creates a novel high-affinity binding site for the SP1 '\n",
      " 'transcription factor, leading to increased MDM2 transcription.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['mdm2', 'sp1', 'mdm2']\n",
      "- - - - - - Original text - - - - -\n",
      "['RNA-seq analysis of patient-derived lymphoblastoid cell lines with the '\n",
      " \"rs2201397 SNP in the TRIM59 3' UTR showed a significant upregulation of \"\n",
      " 'TRIM59 transcript levels, which we hypothesize is due to altered microRNA '\n",
      " 'binding.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['trim', '59', 'trim', '59']\n",
      "- - - - - - Original text - - - - -\n",
      "['Using CRISPR-Cas9 to introduce the rs7552554 variant in the promoter region '\n",
      " 'of the MYB oncogene, we observed a 3-fold increase in H3K27ac histone marks, '\n",
      " 'indicating enhanced enhancer activity.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['myb']\n",
      "- - - - - - Original text - - - - -\n",
      "['The 5-kb deletion upstream of the SOX2 gene was found to completely abrogate '\n",
      " 'the expression of the gene in embryonic stem cells, suggesting the removal '\n",
      " 'of a critical long-range enhancer.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['sox2']\n",
      "- - - - - - Original text - - - - -\n",
      "[\"Our Northern blot analysis revealed that the rs10825036 SNP in the 3' UTR of \"\n",
      " 'the MIR-499 gene resulted in a mature miRNA transcript that was 50% less '\n",
      " 'abundant compared to the wild-type allele.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['mir - 499']\n",
      "- - - - - - Original text - - - - -\n",
      "[\"The 3' UTR of the KRAS gene containing the rs61764370 variant was cloned \"\n",
      " 'into a reporter plasmid, and subsequent luciferase assays showed a '\n",
      " 'significant reduction in luciferase activity, consistent with altered '\n",
      " 'miRNA-mediated repression.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['kras']\n",
      "- - - - - - Original text - - - - -\n",
      "['Chr-RNA FISH experiments confirmed that the C>T mutation in the SHH limb '\n",
      " 'enhancer region failed to form a chromatin loop with the SHH promoter, '\n",
      " 'explaining the observed limb malformations.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['shh', 'shh']\n",
      "- - - - - - Original text - - - - -\n",
      "['Reporter gene assays showed that the rs11603334 SNP in the ARAP1 promoter '\n",
      " 'led to a 2-fold upregulation of gene expression in pancreatic beta cells, '\n",
      " 'which was corroborated by decreased binding of PAX4 and PAX6 transcription '\n",
      " 'factors in EMSA.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['ara', 'p1', 'pax', '4', 'pax6']\n",
      "- - - - - - Original text - - - - -\n",
      "['We used CRISPR-based tiling scans to systematically test variants in the '\n",
      " 'LDLR promoter, finding that a specific A>C substitution reduced promoter '\n",
      " 'activity by 60%, a key finding for familial hypercholesterolemia.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['ldlr']\n",
      "- - - - - - Original text - - - - -\n",
      "['RNA-seq of patient tumor samples with the rs73183594 variant in the IRF4 '\n",
      " 'enhancer showed a significant increase in IRF4 mRNA expression levels, '\n",
      " 'suggesting a gain-of-function mechanism.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['irf', '4', 'irf', '4']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our allele-specific sequencing analysis of RNA from heterozygous individuals '\n",
      " 'demonstrated that the rs3796548 SNP, a non-coding variant, leads to a 3-fold '\n",
      " 'increase in the expression of the TULP3 gene.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['tul', 'p3']\n",
      "- - - - - - Original text - - - - -\n",
      "['The deletion of an enhancer 150 kb upstream of the GATA6 gene was found to '\n",
      " 'cause a loss of GATA6 protein expression in pancreatic progenitor cells, as '\n",
      " 'confirmed by immunostaining.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['gata', '6', 'gata', '6']\n",
      "- - - - - - Original text - - - - -\n",
      "['Quantitative real-time PCR (qRT-PCR) from patient fibroblasts with a deep '\n",
      " 'intronic variant in the IDUA gene revealed a reduced level of the fully '\n",
      " 'spliced transcript and an increase in a mis-spliced isoform.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['id', 'ua']\n",
      "- - - - - - Original text - - - - -\n",
      "['The C>G variant in the promoter of the CASP8 gene, located in a CpG island, '\n",
      " 'was shown by methylation-specific PCR to be associated with a complete loss '\n",
      " 'of DNA methylation and subsequent gene silencing.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['casp', '8']\n",
      "- - - - - - Original text - - - - -\n",
      "['In our chromatin accessibility assay, the A>G SNP in the FTO enhancer was '\n",
      " 'found to disrupt the binding of the ARID5B transcription factor, leading to '\n",
      " 'a downstream effect on gene regulation.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['fto', 'arid', '5b']\n",
      "- - - - - - Original text - - - - -\n",
      "['Our reporter assay demonstrated that the rs1403565 variant in the PITX2 '\n",
      " 'enhancer increased the transcriptional activity of a reporter construct by '\n",
      " '30% in cardiac tissue cells.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['pit', 'x2']\n",
      "- - - - - - Original text - - - - -\n",
      "['The insertion of a SINE retrotransposon into the promoter of the FGFR2 gene '\n",
      " \"was shown by reporter assays to completely abolish the gene's promoter \"\n",
      " 'activity in fibroblasts.']\n",
      "- - Terms tagged of type 'protein' - -\n",
      "['fgfr2']\n"
     ]
    }
   ],
   "source": [
    "filter_res(gemini_gene, \"protein\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 157,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Using a dual-luciferase reporter assay, we demonstrated that the SNP rs6983267, located in a long-range enhancer for the MYC oncogene, significantly increased reporter gene expression by 2.5-fold in colon cancer cell lines.',\n",
       "  [{'entity': 'dual - luciferase reporter assay',\n",
       "    'type': 'experimental_method'},\n",
       "   {'entity': 'rs', 'type': 'gene'},\n",
       "   {'entity': '69', 'type': 'gene'},\n",
       "   {'entity': '83', 'type': 'gene'},\n",
       "   {'entity': '267', 'type': 'gene'},\n",
       "   {'entity': 'long - range enhancer', 'type': 'structure_element'},\n",
       "   {'entity': 'myc', 'type': 'protein_type'}]),\n",
       " ('Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for the transcription factor TCF7L2 revealed a loss of binding at the promoter of the TCF7L2 gene in the presence of the rs7903146 risk allele.',\n",
       "  [{'entity': 'chromatin immunoprecipitation followed by sequencing',\n",
       "    'type': 'experimental_method'},\n",
       "   {'entity': 'chip - seq', 'type': 'experimental_method'},\n",
       "   {'entity': 'transcription factor', 'type': 'protein_type'},\n",
       "   {'entity': 'tcf', 'type': 'protein'},\n",
       "   {'entity': '7', 'type': 'protein'},\n",
       "   {'entity': 'l2', 'type': 'protein'},\n",
       "   {'entity': 'tcf', 'type': 'protein'},\n",
       "   {'entity': '7', 'type': 'protein'},\n",
       "   {'entity': 'l2', 'type': 'protein'}]),\n",
       " (\"Our massively parallel reporter assay (MPRA) data showed that the A>T variant in the 3' UTR of the NOS1AP gene reduced the expression of a linked fluorescent reporter by 40% in cardiomyocyte cells.\",\n",
       "  [{'entity': 'massive', 'type': 'experimental_method'},\n",
       "   {'entity': 'ly parallel reporter assay', 'type': 'experimental_method'},\n",
       "   {'entity': 'mpr', 'type': 'experimental_method'},\n",
       "   {'entity': 'a', 'type': 'experimental_method'},\n",
       "   {'entity': 'a > t', 'type': 'mutant'},\n",
       "   {'entity': \"3 ' utr\", 'type': 'structure_element'},\n",
       "   {'entity': 'nos', 'type': 'protein'},\n",
       "   {'entity': '1a', 'type': 'protein'},\n",
       "   {'entity': 'p', 'type': 'protein'}]),\n",
       " ('Sanger sequencing of the TERT promoter in melanoma samples identified two recurrent non-coding variants, c.-124C>T and c.-146C>T, which were shown by RT-qPCR to increase TERT mRNA expression by 15- and 20-fold, respectively.',\n",
       "  [{'entity': 'sanger sequencing', 'type': 'experimental_method'},\n",
       "   {'entity': 'tert', 'type': 'protein'},\n",
       "   {'entity': 'c . - 124 c > t', 'type': 'mutant'},\n",
       "   {'entity': 'c . - 146 c > t', 'type': 'mutant'},\n",
       "   {'entity': 'rt - qpcr', 'type': 'experimental_method'},\n",
       "   {'entity': 'tert', 'type': 'protein'}]),\n",
       " ('A quantitative chromatin conformation capture (3C) assay demonstrated that the rs9349379 SNP in a genomic insulator element disrupts the physical loop connecting the ESR1 promoter to its upstream enhancer.',\n",
       "  [{'entity': 'quantitative chromatin conformation capture (',\n",
       "    'type': 'experimental_method'},\n",
       "   {'entity': '3c', 'type': 'experimental_method'},\n",
       "   {'entity': '93', 'type': 'gene'},\n",
       "   {'entity': '49', 'type': 'gene'},\n",
       "   {'entity': 'esr1', 'type': 'protein'},\n",
       "   {'entity': 'enhancer', 'type': 'structure_element'}]),\n",
       " ('Minigene splicing assays confirmed that the deep intronic variant IVS21-12C>T in the CFTR gene leads to the creation of a cryptic splice site, resulting in a mis-spliced transcript lacking exon 22.',\n",
       "  [{'entity': 'mini', 'type': 'experimental_method'},\n",
       "   {'entity': 'gene splicing assays', 'type': 'experimental_method'},\n",
       "   {'entity': 'iv', 'type': 'mutant'},\n",
       "   {'entity': 's2', 'type': 'mutant'},\n",
       "   {'entity': '1 - 12 c > t', 'type': 'mutant'},\n",
       "   {'entity': 'cftr', 'type': 'protein'},\n",
       "   {'entity': 'cryptic', 'type': 'site'},\n",
       "   {'entity': 'splice site', 'type': 'site'},\n",
       "   {'entity': 'exon 22', 'type': 'structure_element'}]),\n",
       " ('In a yeast-based screen, we found that a 15-bp deletion within the HBB promoter region completely abolished the binding of the GATA-1 transcription factor, consistent with the observed phenotype in beta-thalassemia patients.',\n",
       "  [{'entity': 'yeast - based screen', 'type': 'experimental_method'},\n",
       "   {'entity': '15', 'type': 'residue_range'},\n",
       "   {'entity': 'deletion', 'type': 'experimental_method'},\n",
       "   {'entity': 'hb', 'type': 'gene'},\n",
       "   {'entity': 'b', 'type': 'gene'},\n",
       "   {'entity': 'gata - 1 transcription factor', 'type': 'protein_type'}]),\n",
       " ('We performed allelic expression analysis on post-mortem brain tissue and found that the rs12913832 SNP in the OCA2 gene enhancer was strongly associated with a 50% decrease in its expression.',\n",
       "  [{'entity': 'allelic expression analysis', 'type': 'experimental_method'},\n",
       "   {'entity': 'rs', 'type': 'gene'},\n",
       "   {'entity': '129', 'type': 'gene'},\n",
       "   {'entity': '138', 'type': 'gene'},\n",
       "   {'entity': '32', 'type': 'gene'},\n",
       "   {'entity': 'oc', 'type': 'protein'},\n",
       "   {'entity': 'a2', 'type': 'protein'}]),\n",
       " ('Our electro mobility shift assay (EMSA) results showed that the C>G SNP in the MDM2 promoter creates a novel high-affinity binding site for the SP1 transcription factor, leading to increased MDM2 transcription.',\n",
       "  [{'entity': 'electro mobility shift assay', 'type': 'experimental_method'},\n",
       "   {'entity': 'emsa', 'type': 'experimental_method'},\n",
       "   {'entity': 'c > g', 'type': 'mutant'},\n",
       "   {'entity': 'mdm2', 'type': 'protein'},\n",
       "   {'entity': 'high - affinity binding site', 'type': 'site'},\n",
       "   {'entity': 'sp1', 'type': 'protein'},\n",
       "   {'entity': 'mdm2', 'type': 'protein'}]),\n",
       " (\"RNA-seq analysis of patient-derived lymphoblastoid cell lines with the rs2201397 SNP in the TRIM59 3' UTR showed a significant upregulation of TRIM59 transcript levels, which we hypothesize is due to altered microRNA binding.\",\n",
       "  [{'entity': 'rna - seq', 'type': 'experimental_method'},\n",
       "   {'entity': '22', 'type': 'gene'},\n",
       "   {'entity': '01', 'type': 'gene'},\n",
       "   {'entity': '397', 'type': 'gene'},\n",
       "   {'entity': 'trim', 'type': 'protein'},\n",
       "   {'entity': '59', 'type': 'protein'},\n",
       "   {'entity': \"3 ' utr\", 'type': 'structure_element'},\n",
       "   {'entity': 'trim', 'type': 'protein'},\n",
       "   {'entity': '59', 'type': 'protein'},\n",
       "   {'entity': 'microrna', 'type': 'chemical'}]),\n",
       " ('Using CRISPR-Cas9 to introduce the rs7552554 variant in the promoter region of the MYB oncogene, we observed a 3-fold increase in H3K27ac histone marks, indicating enhanced enhancer activity.',\n",
       "  [{'entity': 'crispr - cas9', 'type': 'experimental_method'},\n",
       "   {'entity': 'rs7', 'type': 'mutant'},\n",
       "   {'entity': '55', 'type': 'mutant'},\n",
       "   {'entity': '255', 'type': 'mutant'},\n",
       "   {'entity': '4', 'type': 'mutant'},\n",
       "   {'entity': 'myb', 'type': 'protein'}]),\n",
       " ('The 5-kb deletion upstream of the SOX2 gene was found to completely abrogate the expression of the gene in embryonic stem cells, suggesting the removal of a critical long-range enhancer.',\n",
       "  [{'entity': 'deletion', 'type': 'experimental_method'},\n",
       "   {'entity': 'sox2', 'type': 'protein'}]),\n",
       " ('In a high-throughput screen, we identified an A>G variant in the promoter of a lncRNA that significantly decreased its transcription by 75% in a disease-relevant cell model.',\n",
       "  [{'entity': 'high - throughput screen', 'type': 'experimental_method'},\n",
       "   {'entity': 'a > g', 'type': 'residue_name'},\n",
       "   {'entity': 'lncrna', 'type': 'protein_type'}]),\n",
       " (\"Our Northern blot analysis revealed that the rs10825036 SNP in the 3' UTR of the MIR-499 gene resulted in a mature miRNA transcript that was 50% less abundant compared to the wild-type allele.\",\n",
       "  [{'entity': 'northern blot analysis', 'type': 'experimental_method'},\n",
       "   {'entity': 'rs10', 'type': 'gene'},\n",
       "   {'entity': '82', 'type': 'gene'},\n",
       "   {'entity': '50', 'type': 'gene'},\n",
       "   {'entity': '36', 'type': 'gene'},\n",
       "   {'entity': \"3 ' utr\", 'type': 'structure_element'},\n",
       "   {'entity': 'mir - 499', 'type': 'protein'},\n",
       "   {'entity': 'mirna', 'type': 'chemical'},\n",
       "   {'entity': 'wild - type', 'type': 'protein_state'}]),\n",
       " ('Allele-specific chromatin accessibility assays (ATAC-seq) revealed a loss of an open chromatin region at the locus containing the rs12740374 variant, suggesting a disruption of a transcription factor binding site.',\n",
       "  [{'entity': 'allele - specific chromatin accessibility assays',\n",
       "    'type': 'experimental_method'},\n",
       "   {'entity': 'ata', 'type': 'experimental_method'},\n",
       "   {'entity': 'c - seq', 'type': 'experimental_method'},\n",
       "   {'entity': 'rs', 'type': 'mutant'},\n",
       "   {'entity': '127', 'type': 'mutant'},\n",
       "   {'entity': '403', 'type': 'mutant'},\n",
       "   {'entity': '74', 'type': 'mutant'},\n",
       "   {'entity': 'transcription factor binding site', 'type': 'site'}]),\n",
       " (\"The 3' UTR of the KRAS gene containing the rs61764370 variant was cloned into a reporter plasmid, and subsequent luciferase assays showed a significant reduction in luciferase activity, consistent with altered miRNA-mediated repression.\",\n",
       "  [{'entity': \"3 ' utr\", 'type': 'structure_element'},\n",
       "   {'entity': 'kras', 'type': 'protein'},\n",
       "   {'entity': '61', 'type': 'mutant'},\n",
       "   {'entity': '76', 'type': 'mutant'},\n",
       "   {'entity': '43', 'type': 'mutant'},\n",
       "   {'entity': 'luciferase assays', 'type': 'experimental_method'},\n",
       "   {'entity': 'mirna', 'type': 'chemical'}]),\n",
       " ('Chr-RNA FISH experiments confirmed that the C>T mutation in the SHH limb enhancer region failed to form a chromatin loop with the SHH promoter, explaining the observed limb malformations.',\n",
       "  [{'entity': 'chr - rna fish', 'type': 'experimental_method'},\n",
       "   {'entity': 'c > t', 'type': 'mutant'},\n",
       "   {'entity': 'shh', 'type': 'protein'},\n",
       "   {'entity': 'shh', 'type': 'protein'}]),\n",
       " ('Reporter gene assays showed that the rs11603334 SNP in the ARAP1 promoter led to a 2-fold upregulation of gene expression in pancreatic beta cells, which was corroborated by decreased binding of PAX4 and PAX6 transcription factors in EMSA.',\n",
       "  [{'entity': 'reporter gene assays', 'type': 'experimental_method'},\n",
       "   {'entity': 'rs', 'type': 'gene'},\n",
       "   {'entity': '116', 'type': 'gene'},\n",
       "   {'entity': '03', 'type': 'gene'},\n",
       "   {'entity': '33', 'type': 'gene'},\n",
       "   {'entity': '4', 'type': 'gene'},\n",
       "   {'entity': 'ara', 'type': 'protein'},\n",
       "   {'entity': 'p1', 'type': 'protein'},\n",
       "   {'entity': 'pax', 'type': 'protein'},\n",
       "   {'entity': '4', 'type': 'protein'},\n",
       "   {'entity': 'pax6', 'type': 'protein'},\n",
       "   {'entity': 'emsa', 'type': 'experimental_method'}]),\n",
       " ('We used CRISPR-based tiling scans to systematically test variants in the LDLR promoter, finding that a specific A>C substitution reduced promoter activity by 60%, a key finding for familial hypercholesterolemia.',\n",
       "  [{'entity': 'crispr - based til ing scans', 'type': 'experimental_method'},\n",
       "   {'entity': 'ldlr', 'type': 'protein'},\n",
       "   {'entity': 'a > c', 'type': 'mutant'}]),\n",
       " ('RNA-seq of patient tumor samples with the rs73183594 variant in the IRF4 enhancer showed a significant increase in IRF4 mRNA expression levels, suggesting a gain-of-function mechanism.',\n",
       "  [{'entity': 'rna - seq', 'type': 'experimental_method'},\n",
       "   {'entity': 'irf', 'type': 'protein'},\n",
       "   {'entity': '4', 'type': 'protein'},\n",
       "   {'entity': 'irf', 'type': 'protein'},\n",
       "   {'entity': '4', 'type': 'protein'}]),\n",
       " ('Our allele-specific sequencing analysis of RNA from heterozygous individuals demonstrated that the rs3796548 SNP, a non-coding variant, leads to a 3-fold increase in the expression of the TULP3 gene.',\n",
       "  [{'entity': 'allele - specific sequencing analysis',\n",
       "    'type': 'experimental_method'},\n",
       "   {'entity': 'rna', 'type': 'chemical'},\n",
       "   {'entity': 'rs', 'type': 'gene'},\n",
       "   {'entity': '37', 'type': 'gene'},\n",
       "   {'entity': '96', 'type': 'gene'},\n",
       "   {'entity': '54', 'type': 'gene'},\n",
       "   {'entity': '8', 'type': 'gene'},\n",
       "   {'entity': 'tul', 'type': 'protein'},\n",
       "   {'entity': 'p3', 'type': 'protein'}]),\n",
       " ('The deletion of an enhancer 150 kb upstream of the GATA6 gene was found to cause a loss of GATA6 protein expression in pancreatic progenitor cells, as confirmed by immunostaining.',\n",
       "  [{'entity': 'deletion of', 'type': 'experimental_method'},\n",
       "   {'entity': 'enhancer', 'type': 'structure_element'},\n",
       "   {'entity': 'gata', 'type': 'protein'},\n",
       "   {'entity': '6', 'type': 'protein'},\n",
       "   {'entity': 'gata', 'type': 'protein'},\n",
       "   {'entity': '6', 'type': 'protein'},\n",
       "   {'entity': 'immunostaining', 'type': 'experimental_method'}]),\n",
       " ('Using a high-resolution 4C-seq, we mapped the chromosomal interactions of the genomic region containing a non-coding variant, revealing the creation of a novel chromatin loop between a distant enhancer and an oncogene.',\n",
       "  [{'entity': '4c - seq', 'type': 'experimental_method'}]),\n",
       " (\"A minigene assay showed that a single nucleotide variant (G>A) in the 5' untranslated region of an unknown gene caused an increase in ribosome readthrough and protein translation.\",\n",
       "  [{'entity': 'mini', 'type': 'experimental_method'},\n",
       "   {'entity': 'gene assay', 'type': 'experimental_method'},\n",
       "   {'entity': 'g > a', 'type': 'mutant'},\n",
       "   {'entity': \"5 ' untranslated region\", 'type': 'structure_element'}]),\n",
       " ('Quantitative real-time PCR (qRT-PCR) from patient fibroblasts with a deep intronic variant in the IDUA gene revealed a reduced level of the fully spliced transcript and an increase in a mis-spliced isoform.',\n",
       "  [{'entity': 'quantitative real - time pcr', 'type': 'experimental_method'},\n",
       "   {'entity': 'qrt - pcr', 'type': 'experimental_method'},\n",
       "   {'entity': 'id', 'type': 'protein'},\n",
       "   {'entity': 'ua', 'type': 'protein'},\n",
       "   {'entity': 'fully spliced', 'type': 'protein_state'}]),\n",
       " ('The C>G variant in the promoter of the CASP8 gene, located in a CpG island, was shown by methylation-specific PCR to be associated with a complete loss of DNA methylation and subsequent gene silencing.',\n",
       "  [{'entity': 'c > g', 'type': 'mutant'},\n",
       "   {'entity': 'casp', 'type': 'protein'},\n",
       "   {'entity': '8', 'type': 'protein'},\n",
       "   {'entity': 'cpg island', 'type': 'site'},\n",
       "   {'entity': 'methylation - specific pcr', 'type': 'experimental_method'}]),\n",
       " ('In our chromatin accessibility assay, the A>G SNP in the FTO enhancer was found to disrupt the binding of the ARID5B transcription factor, leading to a downstream effect on gene regulation.',\n",
       "  [{'entity': 'chromatin accessibility assay', 'type': 'experimental_method'},\n",
       "   {'entity': 'a > g', 'type': 'mutant'},\n",
       "   {'entity': 'fto', 'type': 'protein'},\n",
       "   {'entity': 'arid', 'type': 'protein'},\n",
       "   {'entity': '5b', 'type': 'protein'}]),\n",
       " ('Our reporter assay demonstrated that the rs1403565 variant in the PITX2 enhancer increased the transcriptional activity of a reporter construct by 30% in cardiac tissue cells.',\n",
       "  [{'entity': 'reporter assay', 'type': 'experimental_method'},\n",
       "   {'entity': 'rs', 'type': 'mutant'},\n",
       "   {'entity': '140', 'type': 'mutant'},\n",
       "   {'entity': '35', 'type': 'mutant'},\n",
       "   {'entity': '65', 'type': 'mutant'},\n",
       "   {'entity': 'pit', 'type': 'protein'},\n",
       "   {'entity': 'x2', 'type': 'protein'}]),\n",
       " (\"The insertion of a SINE retrotransposon into the promoter of the FGFR2 gene was shown by reporter assays to completely abolish the gene's promoter activity in fibroblasts.\",\n",
       "  [{'entity': 'sine retrotranspos on', 'type': 'protein_type'},\n",
       "   {'entity': 'fgfr2', 'type': 'protein'},\n",
       "   {'entity': 'reporter assays', 'type': 'experimental_method'}]),\n",
       " ('CRISPR activation experiments using a sgRNA targeting the promoter region of a lncRNA confirmed that a non-coding variant within this region was responsible for a significant reduction in gene expression.',\n",
       "  [{'entity': 'crispr activation experiments', 'type': 'experimental_method'},\n",
       "   {'entity': 'sgrna', 'type': 'chemical'},\n",
       "   {'entity': 'lncrna', 'type': 'protein_type'}])]"
      ]
     },
     "execution_count": 157,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gemini_gene"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### AE classifier - not worth chasing"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "df6aad8a796d4ccbb5788b36f4d14735",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "tokenizer_config.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "72e56c739b5d4f08b79c645d0024afbf",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "vocab.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "14438c5c824541078ac5306114e4e2e1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "merges.txt: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "614aade323e346d58bb110b088ef411f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "tokenizer.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "12d0e98825d44eeda503e29a2ecdeb92",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "special_tokens_map.json:   0%|          | 0.00/964 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "497cfddc01464d0cb3ea2640ab058a08",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "config.json:   0%|          | 0.00/961 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "95371f9790e0450182830b66b4d6dc79",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "model.safetensors:   0%|          | 0.00/595M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from transformers import AutoTokenizer, AutoModelForSequenceClassification\n",
    "\n",
    "# This model is a classifier: AE is / is not present in text\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"jocforero/longformer-adverse-event-classifier\")\n",
    "ae_model = AutoModelForSequenceClassification.from_pretrained(\"jocforero/longformer-adverse-event-classifier\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "gemini_ae_egs = [\n",
    "    \"Gastrointestinal bleeding occurred in two patients receiving the active treatment.\"\n",
    "    \"One participant in the control group experienced anaphylactic shock requiring immediate medical intervention.\",\n",
    "    \"The most frequently reported adverse event was mild-to-moderate headache, observed in 15% of the study population.\",\n",
    "    \"Three cases of acute renal failure were documented, leading to discontinuation of the study drug.\",\n",
    "    \"A dose-dependent increase in serum transaminases was observed in a subset of participants.\",\n",
    "    \"The device's implantation was associated with local tissue necrosis in 5% of subjects.\",\n",
    "    \"A single instance of pulmonary embolism was reported in a patient with no prior history of thrombotic events.\",\n",
    "    \"Patients on the higher dose of the compound exhibited a significant increase in systolic blood pressure.\",\n",
    "    \"Study withdrawal was attributed to unmanageable nausea and vomiting in four subjects.\",\n",
    "    \"One participant developed a maculopapular rash that was determined to be a hypersensitivity reaction to the study medication.\",\n",
    "    \"This is a test, nothing to see here.\", # Should be false, completely out of context\n",
    "    \"The study was conducted in a double-blind, placebo-controlled manner.\", # Should be false, in context but 0 AE\n",
    "    \"An adverse event of headache was reported.\" # Can't get much more obvious a statement\n",
    "    ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Gastrointestinal bleeding occurred in two patients receiving the active treatment.One participant in the control group experienced anaphylactic shock requiring immediate medical intervention.', 'The most frequently reported adverse event was mild-to-moderate headache, observed in 15% of the study population.', 'Three cases of acute renal failure were documented, leading to discontinuation of the study drug.', 'A dose-dependent increase in serum transaminases was observed in a subset of participants.']\n",
      "tensor([0, 0, 0, 0])\n",
      "{0: 'LABEL_0', 1: 'LABEL_1'}\n",
      "[\"The device's implantation was associated with local tissue necrosis in 5% of subjects.\", 'A single instance of pulmonary embolism was reported in a patient with no prior history of thrombotic events.', 'Patients on the higher dose of the compound exhibited a significant increase in systolic blood pressure.', 'Study withdrawal was attributed to unmanageable nausea and vomiting in four subjects.']\n",
      "tensor([0, 0, 0, 0])\n",
      "{0: 'LABEL_0', 1: 'LABEL_1'}\n",
      "['One participant developed a maculopapular rash that was determined to be a hypersensitivity reaction to the study medication.', 'This is a test, nothing to see here.', 'The study was conducted in a double-blind, placebo-controlled manner.', 'An adverse event of headache was reported.']\n",
      "tensor([0, 0, 0, 0])\n",
      "{0: 'LABEL_0', 1: 'LABEL_1'}\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "\n",
    "batch_size=4\n",
    "max_length=512\n",
    "\n",
    "all_results = []\n",
    "    \n",
    "# Process in batches\n",
    "for i in range(0, len(gemini_ae_egs), batch_size):\n",
    "    # Get the current batch\n",
    "    batch_texts = gemini_ae_egs[i:i + batch_size]\n",
    "    \n",
    "    # Tokenize and pass to model\n",
    "    inputs = tokenizer(batch_texts, return_tensors=\"pt\", padding=True, truncation=True, max_length=max_length)\n",
    "    print(batch_texts)\n",
    "    with torch.no_grad():\n",
    "        outputs = ae_model(**inputs)\n",
    "\n",
    "    # Decode predictions and configure id to label map\n",
    "    predictions = torch.argmax(outputs.logits, dim=1)\n",
    "    print(predictions)\n",
    "    id_to_label = ae_model.config.id2label\n",
    "    print(id_to_label)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ner-model",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
